Manganese enhances macrophage bactericidal activity in mice with Staphylococcus aureus osteomyelitis via Sirt3-mitophagy axis Authors: Xin Guan, Bingsheng Yang, Bowen Bai, Naiqian Cui, Muqi Wang, Jianwen Su, Xiaohu Wu, Chenghua Zhang, Hui Dai, Peng Zhao, Bin Yu, Bowei Wang Published: 2026 ABSTRACT Staphylococcus aureus (S. aureus)-induced osteomyelitis remains challenging in clinical practice, wherein macrophages with impaired bactericidal function serve as reservoirs for intracellular bacterial survival, contributing to persistent and relapsing infections. Here, we show that exogenous manganese (Mn2+) enhances the bactericidal capacity of S. aureus-infected macrophages. By repressing the mitochondrial protein Sirt3, Mn2+ inhibits S. aureus-induced mitophagy via the PTEN-induced kinase 1/parkin pathway, thereby boosting the production of mitochondrial reactive oxygen species to eradicate intracellular bacteria. Pharmacological activation or genetic overexpression of Sirt3 abolishes these effects, identifying this axis as a key molecular target of Mn2+. Based on this, we further develop a biomimetic nanotherapeutic system for targeted Mn2+ delivery. In a mouse model of osteomyelitis, this nanosystem precisely represses Sirt3 in macrophages within the infected medullary cavity, markedly reduces bacterial burden, and effectively alleviates bone destruction. Our findings implicate an immunomodulatory mechanism by which Mn2+ enhances macrophage bactericidal activity and develops a potent Mn2+-based metalloimmunotherapeutical strategy for S. aureus-induced osteomyelitis. Introduction Infectious osteomyelitis represents a major severe complication following fractures and orthopedic surgeries1, with Staphylococcus aureus (S. aureus) as the most prevalent causative pathogen2,3. During S. aureus-induced osteomyelitis (SIOM), infected bone often exhibits chronic and persistent inflammation, resilient and enduring infection, along with progressive bone destruction1,4. Despite prolonged high-dose antibiotics combined with surgical debridement, clinical outcomes remain suboptimal, largely because of complex pathogen–host interactions. S. aureus employs various immune evasion mechanisms, including biofilm forming, host cell signaling hijacking, and cellular internalization, to support their long-term survival5. Notably, macrophage, a front-line innate immune cell, paradoxically serves as a primary reservoir for the invaded S. aureus with attenuated intracellular killing ability6–10. These together pose great challenges to complete bacteria eradication, and the rates of treatment failure and infection recurrence have reached 37.9% and 25.9%, respectively11,12, highlighting the urgent demand for effective therapeutic strategies accordingly. Mitochondrion-derived reactive oxygen species (mtROS) is proposed to directly contribute to macrophage bactericidal activity13,14. Stimulated by pathogen invasion, mitochondria are recruited to phagosomes containing bacteria, initiating the production of mtROS for bacterial killing15–18. During the process, inhibition of mitophagy is considered a major mechanism leading to an increase in mtROS15,19,20. However, intracellular bacterial pathogens, such as Listeria and Mycobacterium tuberculosis, are reported to induce mitophagy to retard macrophages’ immune defense21–23, and so does S. aureus24. Recent studies from our laboratory have elaborated the enhanced mitophagy and reduced mtROS production in macrophages via S. aureus-triggered PD-1/PD-L1 signaling pathway25. Besides, S. aureus-amplified EGFR-MEK1/2 cascade is also found to negatively regulate the bactericidal function of macrophages by reducing mtROS production26, which is speculated to result from the upregulated mitophagy27. In this regard, it could be a promising immunomodulatory strategy to target mitophagy-mtROS axis to enhance macrophage bactericidal function for treating SIOM. Since many metal ions were highlighted to play essential roles in immune regulation, metalloimmunotherapy has emerged as an alternative approach for disease treatment28. Among them, Mn2+ has attracted intensive attention with a potent immune-stimulating property. Jiang and colleagues demonstrated that Mn2+ primes innate antiviral immunity by sensitizing cGAS to cytosolic dsDNA and enhancing STING activation29, and manganese-based immunotherapies have been widely explored for reversing the tumor immunosuppressive microenvironment30–32. In bacterial infection, however, host-directed manganese biology has mainly been discussed in the context of nutritional immunity, where the host limits Mn availability to restrict bacterial growth and sensitize pathogens to oxidative stress33–35, the potential of Mn2+ as an active immunomodulatory agent to boost host’s immune response in bacterial infectious diseases still remains largely unexplored. Considering the similarities between tumorous and bacteria-infectious immune microenvironment, Mn2+ is a highly promising candidate for the metalloimmunotherapy in treating SIOM. In recent years, many studies have linked manganese exposure to altered mitophagy in neuronal cells36,37, raising the possibility that Mn2+ might also modulate mitophagy in infected macrophages. In preliminary experiments, we observed that exogenous Mn2+ suppresses mitophagy in S. aureus-infected macrophages, accompanied by increased mtROS and enhanced bacterial clearance. Moreover, sirtuin-3 (Sirt3), an NAD+-dependent deacetylase in mitochondria, was also identified substantially downregulated during the process. Given that Sirt3 plays an essential role in regulating mitochondrial oxidative stress and inducing mitophagy38–40, it is hypothesized that Mn2+ may exert the mitophagy inhibition effect through interfering with Sirt3, thus enhancing the mtROS production and recovering the bactericidal activity in S. aureus-infected macrophages. Herein, we demonstrate that exogenous Mn2+ efficiently enhances the bactericidal function of S. aureus-infected macrophages by repressing Sirt3, thereby inhibiting PINK1/Parkin-mediated mitophagy and augmenting mtROS. Based on this finding, we further construct a macrophage membrane-coated MnO-loaded ZIF-8 (denoted as MZM) nano-system that enables inflammatory-site targeting and efficient intracellular Mn2+ delivery. The synthesized MZM precisely enhanced the bactericidal activity of macrophages and has gained satisfactory efficacy in SIOM mice model (Supplementary Schematic illustration). Taken together, our work not only proposes a distinct exogenous Mn2+-possessed immunomodulatory mechanism in S. aureus-infected macrophage, but also develops an effective Mn2+-based metalloimmunotherapy for treating SIOM, both of which provide a promising strategy for bacterial infectious diseases and merit a wider and more in-depth exploration. Results Macrophages with impaired bactericidal capacity contribute to the intracellular bacterial burden in SIOM Previous findings from our laboratory suggested that the pathogenesis of SIOM was accompanied by an immunosuppressive microenvironment in infected medullary cavity9,25,41. To define the immune-cell landscape and cell-state changes during disease progression, we analyzed the transcriptomic datasets from infected murine bone tissues on day 7 (GSE227521) and day 14 (GSE166522) post-S. aureus infection41,42 (Table S1). Differentially expressed genes (DEGs) from the two datasets were merged and subjected to Gene Ontology (GO) enrichment analysis. Consistent with the prior work, biological process (GO. BP) enrichment highlighted “negative regulation of immune system process”, together with pathways related to innate immune cells (monocytes, macrophages, and neutrophils) and adaptive immune cells (T and B lymphocytes) (Fig. 1A). Immune cell-infiltration analysis further confirmed that neutrophils and monocyte-macrophages constituted the predominant populations at both days 7 and 14, with a significant increase in monocytes/macrophages by day 14 (Fig. 1B). We then intersected immune cell-related DEGs with those annotated to “negative regulation of immune system process” (Fig. 1C, Fig. S1). UpSet Venn plot showed the greatest overlap in monocyte-macrophage (Fig. 1D, E). Together, these profiles corroborate that the SIOM microenvironment is characterized by a dysregulated innate immune response dominated by macrophage infiltration.Fig. 1Macrophages with impaired bactericidal capacity contribute to intracellular bacterial burden in Staphylococcus aureus (S. aureus)-induced osteomyelitis (SIOM).A-E Transcriptomic re-analysis of datasets GSE227521 and GSE166522. A, Gene Ontology (GO) biological process enrichment of differentially expressed genes (DEGs). B, Immune cell infiltration estimated using the CIBERSORT algorithm. C, Enrichment of pathways related to negative regulation of immune responses. D, E Venn plot (D) and UpSet plot (E) showing overlap between immune cell-associated DEGs and DEGs within the negative immune regulation pathway. F–J Representative immunofluorescence images of femoral bone marrow from SIOM mice and non-infected controls stained for S. aureus (green) and F4/80 (macrophages, red). Yellow arrows indicate F4/80⁺ macrophages containing S. aureus. G, H, I Quantification of F4/80⁺ area (G), S. aureus⁺ area (H), and F4/80⁺S. aureus⁺ area (I) normalized to total bone marrow area. J Ratio of F4/80⁺S. aureus⁺ area to total S. aureus⁺ area. 3D, 7D, and 14D denote days 3, 7, and 14 post-surgery. Scale bar, 50 μm. n = 3/group. K–O Transcriptomic re-analysis of GSE102444. K GO functional enrichment of DEGs. L Heatmap of mitochondria-related DEGs. M–O Gene set enrichment analysis (GSEA) indicating upregulation of mitophagy-related biological processes in S. aureus-infected macrophages compared with controls. P, Q Representative images (P) and quantification (Q) of mitochondrial ROS (mtROS) in bone marrow-derived macrophages (BMDMs) infected with S. aureus (MOI = 10) at the indicated time points (0, 3, 6, 9, and 12 h). Scale bar, 20 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Macrophages with impaired bactericidal capacity contribute to intracellular bacterial burden in Staphylococcus aureus (S. aureus)-induced osteomyelitis (SIOM). A-E Transcriptomic re-analysis of datasets GSE227521 and GSE166522. A, Gene Ontology (GO) biological process enrichment of differentially expressed genes (DEGs). B, Immune cell infiltration estimated using the CIBERSORT algorithm. C, Enrichment of pathways related to negative regulation of immune responses. D, E Venn plot (D) and UpSet plot (E) showing overlap between immune cell-associated DEGs and DEGs within the negative immune regulation pathway. F–J Representative immunofluorescence images of femoral bone marrow from SIOM mice and non-infected controls stained for S. aureus (green) and F4/80 (macrophages, red). Yellow arrows indicate F4/80⁺ macrophages containing S. aureus. G, H, I Quantification of F4/80⁺ area (G), S. aureus⁺ area (H), and F4/80⁺S. aureus⁺ area (I) normalized to total bone marrow area. J Ratio of F4/80⁺S. aureus⁺ area to total S. aureus⁺ area. 3D, 7D, and 14D denote days 3, 7, and 14 post-surgery. Scale bar, 50 μm. n = 3/group. K–O Transcriptomic re-analysis of GSE102444. K GO functional enrichment of DEGs. L Heatmap of mitochondria-related DEGs. M–O Gene set enrichment analysis (GSEA) indicating upregulation of mitophagy-related biological processes in S. aureus-infected macrophages compared with controls. P, Q Representative images (P) and quantification (Q) of mitochondrial ROS (mtROS) in bone marrow-derived macrophages (BMDMs) infected with S. aureus (MOI = 10) at the indicated time points (0, 3, 6, 9, and 12 h). Scale bar, 20 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Macrophages are critical first-line effectors against S. aureus, coordinating pathogen phagocytosis, cytokine production, and intracellular killing43. However, the internalized S. aureus is reported to impair intracellular killing ability of macrophages, making them the primary reservoir for pathogen colonies in the host6,7,10,44. We therefore examined macrophage recruitment and bacterial burden during the pathogenesis of SIOM in mice. Immunofluorescence staining revealed robust accumulation of F4/80+ macrophages surrounding abscess lesions as early as day 3 post-infection, with further increases on days 7 and 14 (Fig. 1F, G). Meanwhile, the S. aureus signal (green) still expanded within the medullary cavity as disease progressed. Notably, colocalization of S. aureus with F4/80⁺ macrophages increased substantially by day 7 and became more pronounced by day 14 (Fig. 1F–J, Figure S2), indicating an escalating intracellular bacterial burden consistent with compromised macrophage killing capacity during the progress of osteomyelitis. To explore the mechanisms underlying impaired bactericidal activity in S. aureus-infected macrophages, we analyzed the transcriptomic data from alveolar macrophages with and without S. aureus infection (GSE102444)45. GO analysis showed that DEGs were enriched in mitochondria-related biological processes and cellular components (Fig. 1K), with a predominance of upregulated mitochondria-associated genes (Fig. 1L). Gene set enrichment analysis (GSEA) specifically pinpointed remarkable activation of mitophagy in infected cells (Fig. 1M–O), directing our focus toward mitochondria-related mechanisms. Given that inhibition of mitophagy leads to an increase in mtROS, and that mtROS directly contributes to macrophage bactericidal activity20, we next monitored mtROS dynamics in primary murine bone marrow-derived macrophages (BMDMs) following S. aureus infection. Results showed that mtROS rapidly increased and peaked at 6 h post-infection, but declined markedly by 9 h post-infection (Fig. 1P, Q). These findings are consistent with S. aureus-induced mitophagy and a concomitant reduction in mtROS, which contribute to impaired macrophages’ bactericidal capacity. Thus, targeting the mitophagy-mtROS axis represents a rational immunomodulatory strategy to enhance macrophage antibacterial function for SIOM treatment. Exogenous Mn2+enhanced the bactericidal function of BMDMs via augmentation of mtROS Metal immunology, a flourishing interdisciplinary subject in recent years, has highlighted potent immunoregulatory effects of diverse metal ions28, and Mn2+ in particular has been leveraged in metalloimmunotherapy to enhance antitumor immunity30–32. We therefore wonder if exogenous Mn2+ could strengthen macrophage defense against S. aureus. The effect of exogenous Mn2+ on BMDMs’ phagocytosis ability was assessed. Cells were pretreated with Mn2+ at various concentrations (25, 50, 100 μM) for 12 h and then infected by S. aureus at MOI of 10 for 1 h. After removal of external bacteria, bacterial uptake was quantified by colony counting. Unexpectedly, no significant difference was observed among the control and the Mn2+-treated groups (Figure S3), suggesting that Mn2+ has negligible impact on the phagocytic capacity of BMDMs under these conditions. The bactericidal ability was then investigated. Following the 1 h infection and extracellular bacterial removal, infected BMDMs were further incubated for 12 h and intracellular bacterial survival was quantified. The result revealed that Mn2+ significantly reduced bacterial colonies in a dose-dependent manner (Fig. 2A, B). Immunofluorescence further confirmed the enhanced intracellular bacteria eradication in the Mn2+-treated groups (Fig. 2C, D), indicating that exogenous Mn2+ efficiently enhanced the bactericidal activity of BMDMs. Given the importance of proinflammatory cytokines in immune defense against S. aureus infection, we further assessed the effect of Mn2+ in regulating inflammatory responses. It was found that S. aureus infection significantly up-regulated the expression of TNF-α, IL-1β, and IL-6 mRNA, while Mn2+ further enhanced the expression of those proinflammatory factors (Fig. 2E–G). Collectively, these results suggest that exogenous Mn2+ enhances macrophage bactericidal capacity during S. aureus infection, accompanied by amplified immune response.Fig. 2Exogenous Mn2+ enhances the bactericidal activity of bone marrow-derived macrophages (BMDMs) by augmenting mitochondrial ROS (mtROS).A, B Representative agar plate images (A) and quantification (B) of bacterial burden in BMDMs infected with Staphylococcus aureus (S. aureus) (MOI = 10) and treated with Mn2+ at the indicated concentrations (25, 50, 100 μM). n = 5 biological independent experiments. C, D Representative immunofluorescence images (C) and quantification (D) of intracellular S. aureus in infected BMDMs treated with Mn2+ (25, 50, 100 μM). Scale bar, 20 μm. n = 5/group. E–G mRNA expression of pro-inflammatory cytokines (Tnf-α, Il-6, Il-1β) in S. aureus-infected BMDMs (MOI = 10) treated with Mn2+ (25, 50, 100 μM). n = 5 biological independent experiments. H, I Representative flow cytometry plots (H) and quantification (I) of mtROS in S. aureus-infected BMDMs treated with Mn2+ (100 μM) at the indicated times (0, 3, 6, 9, and 12 h). n = 5/group. J, K Representative flow cytometry plots (J) and quantification (K) of mtROS in S. aureus-infected BMDMs at 12 h post-infection treated with Mn2+ (25, 50, 100 μM). n = 5/group. L, M Representative images (L) and quantification (M) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) plus mtTEMPO (100 μM). n = 5 biological independent experiments. N, O Representative immunofluorescence images (N) and quantification (O) of intracellular S. aureus in BMDMs from the indicated groups. Scale bar, 20 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Exogenous Mn2+ enhances the bactericidal activity of bone marrow-derived macrophages (BMDMs) by augmenting mitochondrial ROS (mtROS). A, B Representative agar plate images (A) and quantification (B) of bacterial burden in BMDMs infected with Staphylococcus aureus (S. aureus) (MOI = 10) and treated with Mn2+ at the indicated concentrations (25, 50, 100 μM). n = 5 biological independent experiments. C, D Representative immunofluorescence images (C) and quantification (D) of intracellular S. aureus in infected BMDMs treated with Mn2+ (25, 50, 100 μM). Scale bar, 20 μm. n = 5/group. E–G mRNA expression of pro-inflammatory cytokines (Tnf-α, Il-6, Il-1β) in S. aureus-infected BMDMs (MOI = 10) treated with Mn2+ (25, 50, 100 μM). n = 5 biological independent experiments. H, I Representative flow cytometry plots (H) and quantification (I) of mtROS in S. aureus-infected BMDMs treated with Mn2+ (100 μM) at the indicated times (0, 3, 6, 9, and 12 h). n = 5/group. J, K Representative flow cytometry plots (J) and quantification (K) of mtROS in S. aureus-infected BMDMs at 12 h post-infection treated with Mn2+ (25, 50, 100 μM). n = 5/group. L, M Representative images (L) and quantification (M) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) plus mtTEMPO (100 μM). n = 5 biological independent experiments. N, O Representative immunofluorescence images (N) and quantification (O) of intracellular S. aureus in BMDMs from the indicated groups. Scale bar, 20 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Given the established role of mtROS in macrophage bactericidal activity13,20,43,46, it is speculated that the Mn2+-enhanced function is exerted by restoring the S. aureus-suppressed mtROS production. Therefore, we monitored mtROS level using mitoSOX Red reagent via flow cytometry. Consistent with our previous observation25,26, the level of mtROS in control group underwent a biphasic alteration, with an initial upward surge followed by a downward declination (Fig. 2H, I). In contrast, Mn2+ administration markedly rescued the decrease of mtROS, maintaining elevated mtROS levels within 12 h post-infection (Fig. 2H, I). Moreover, mtROS levels at 12 h post-infection increased in a Mn2+ dose-dependent manner (Fig. 2J, K). These findings suggest that Mn2+ robustly amplifies mtROS production of S. aureus-infected BMDMs. To determine whether Mn2+-augmented mtROS is functionally required for enhanced bacterial killing, we performed loss-of-function experiments using the mitochondrial ROS scavenger mitoTEMPO (Figure S4A–F). As a result, mtTEMPO substantially diminished the Mn2+-enhanced bactericidal activity (Fig. 2L, M) and increased intracellular bacterial residency as visualized by immunofluorescence (Fig. 2N, O). By contrast, the NOX2 inhibitor DPI failed to abrogate the Mn2+-enhanced bactericidal activity, although it reduced basal bacterial clearance (Fig. S4G, H). Together, these results indicate that exogenous Mn2+ augments the mtROS production of S. aureus-infected BMDMs, thus enhancing cellular bactericidal capacity. The augmented mtROS production primarily originated from Mn2+-inhibited mitophagy The origin of augmented mtROS was then investigated. It is known that mitochondria function and mitophagy are linked to mtROS production15,19,47, we thus examined the morphology of mitochondria in BMDMs from different groups (uninfected, S. aureus-infected, and S. aureus-infected with Mn2+ administration) by transmission electron microscopy (TEM). As shown in Fig. 3A, mitochondria exhibited clear morphology with intact cristae in uninfected BMDMs. In contrast, majority of the mitochondria in S. aureus-infected BMDMs were enclosed and degraded in autophagosome/autolysosomes. Notably, the mitochondria in the Mn2+-treated group displayed a defective state with obviously broken cristae-comparable to infected controls, but with markedly fewer autophagosome/autolysosomes forming (Fig. 3A–C). This observation suggests that S. aureus intensively induces mitophagy, whereas Mn2+ administration significantly interferes with this process. To further assess mitophagy, we quantified mitochondria-lysosome colocalization by co-staining with MitoTracker and LysoTracker. Indicated in Fig. 3D, S. aureus infection increased mitochondria-lysosome co-localization, whereas Mn2+ treatment significantly reduced this signal (Fig. 3E, F), supporting inhibition of S. aureus-induced mitophagy. Induction of mitophagy is associated with a drop in mitochondrial membrane potential (Δψm), while high Δψm is concomitant with the inhibition of mitophagy48. JC-1 probe was then utilized for visualization of Δψm (green monomers indicating low Δψm; red aggregates indicating high Δψm). In line with this, S. aureus-infected BMDMs displayed increased JC-1 monomers, while Mn2+-treated BMDMs showed increased JC-1 aggregates, exhibiting an effective rescue of Δψm decrease by Mn2+ administration (Fig. 3G, H). Collectively, these results indicate that exogenous Mn2+ efficiently causes the inhibition of mitophagy in S. aureus-infected BMDMs. To identify the role of Mn2+-inhibited mitophagy in Mn2+-augmented mtROS production, carbonyl cyanide m-chlorophenylhydrazone (CCCP) was additionally employed to activate the mitophagy process. CCCP-activated mitophagy substantially blunted Mn2+-associated mtROS elevation (Fig. 3I, J) and consequently diminished the enhanced bactericidal activity observed in Mn2+-treated BMDMs (Fig. 3K, L). Together, these results verify that the enhancement of mtROS production and bactericidal activity primarily originated from Mn2+-mediated mitophagy inhibition in S. aureus-infected BMDMs.Fig. 3Enhanced mitochondrial ROS (mtROS) production is primarily attributable to Mn2+-mediated inhibition of mitophagy.A–C Representative transmission electron microscopy (TEM) images showing mitochondrial ultrastructure in bone marrow-derived macrophages (BMDMs) that were uninfected or infected with Staphylococcus aureus (S. aureus) (MOI = 10) and treated with or without Mn2+ (100 μM). Blue arrows indicate morphologically normal mitochondria; green arrows indicate mitochondria enclosed within lysosomal structures; red arrows indicate damaged mitochondria; yellow arrows indicate intracellular S. aureus. B, Quantification of abnormal mitochondria per cell. C, Quantification of mitochondria engulfed by lysosomes per cell. Scale bars, 2 μm and 500 nm. n = 5/group. D–F Representative fluorescence images (D) and quantification (E, F) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. E, Pearson’s correlation coefficients. F, MitoTracker-LysoTracker overlap ratios. Scale bar, 50 μm. n = 5/group. G, H Representative fluorescence images (G) and quantification (H) of JC-1 staining in BMDMs from the indicated groups. H, Ratio of JC-1 aggregates to JC-1 monomers. Scale bar, 50 μm. n = 5/group. I, J Representative flow cytometry plots (I) and quantification (J) assessing mitochondrial ROS in uninfected or S. aureus-infected BMDMs (MOI = 10) treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) + carbonyl cyanide m-chlorophenylhydrazone (CCCP). n = 5/group. K, L Representative images (K) and quantification (L) of bacterial burden in BMDMs from the indicated treatment groups. n = 6 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Enhanced mitochondrial ROS (mtROS) production is primarily attributable to Mn2+-mediated inhibition of mitophagy. A–C Representative transmission electron microscopy (TEM) images showing mitochondrial ultrastructure in bone marrow-derived macrophages (BMDMs) that were uninfected or infected with Staphylococcus aureus (S. aureus) (MOI = 10) and treated with or without Mn2+ (100 μM). Blue arrows indicate morphologically normal mitochondria; green arrows indicate mitochondria enclosed within lysosomal structures; red arrows indicate damaged mitochondria; yellow arrows indicate intracellular S. aureus. B, Quantification of abnormal mitochondria per cell. C, Quantification of mitochondria engulfed by lysosomes per cell. Scale bars, 2 μm and 500 nm. n = 5/group. D–F Representative fluorescence images (D) and quantification (E, F) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. E, Pearson’s correlation coefficients. F, MitoTracker-LysoTracker overlap ratios. Scale bar, 50 μm. n = 5/group. G, H Representative fluorescence images (G) and quantification (H) of JC-1 staining in BMDMs from the indicated groups. H, Ratio of JC-1 aggregates to JC-1 monomers. Scale bar, 50 μm. n = 5/group. I, J Representative flow cytometry plots (I) and quantification (J) assessing mitochondrial ROS in uninfected or S. aureus-infected BMDMs (MOI = 10) treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) + carbonyl cyanide m-chlorophenylhydrazone (CCCP). n = 5/group. K, L Representative images (K) and quantification (L) of bacterial burden in BMDMs from the indicated treatment groups. n = 6 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Exogenous Mn2+inhibited the mitophagy in S. aureus-infected BMDMs via the PINK1-Parkin signaling pathway Experimental evidence demonstrates that PINK1-Parkin-mediated mitophagy serves as a primary pathway in S. aureus-induced mitophagy24,49. We subsequently investigated whether exogenous Mn2+ exerts inhibitory effects through this specific mechanism. As expected, S. aureus increased PINK1 abundance and Parkin phosphorylation (p-Parkin) in BMDMs, accompanied by an elevated LC3B-II/I ratio and reduced SQSTM1/p62 levels at 12 h post-infection (Fig. 4A, B), consistent with mitophagy activation. Notably, Mn2+ administration dose-dependently attenuated PINK1-Parkin signaling and concurrently reversed the LC3B II/I ratio increase and p62 reduction (Fig. 4A, B), indicating notable pathway inhibition. To elucidate the pathway-specific involvement, we activated PINK1 pharmacologically using MTK458 during S. aureus infection in Mn2+-treated BMDMs. Western blot analysis revealed that MTK458 effectively counteracted the Mn2+-mediated LC3b II/I ratio suppression and p62 elevation (Fig. 4C, D), with a clear dose-dependent restoration observed (Fig. 4E, F). Consistently, fluorescent mitophagy assessment displayed that MTK458 reversed Mn2+-induced decrease in mitochondria-lysosome colocalization (Fig. 4G–I). JC-1 staining further showed MTK458 reduced the elevated Δψm observed in Mn2+-treated BMDMs (Fig. 4J, K). Collectively, these findings confirm that PINK1 activation counteracts Mn2+-mediated mitophagy inhibition, supporting that exogenous Mn2+ suppresses S. aureus-induced mitophagy specifically through PINK1-Parkin pathway in BMDMs.Fig. 4Exogenous Mn2+ inhibits mitophagy in Staphylococcus aureus (S. aureus)-infected bone marrow-derived macrophages (BMDMs) via the PINK1-Parkin pathway.A, B Western blot analysis (A) and densitometric quantification (B) of PINK1-Parkin pathway-related proteins in BMDMs that were uninfected or infected with S. aureus (MOI = 10) and treated with or without Mn2+ (100 μM). n = 5 biological independent experiments. C, D Western blot analysis (C) and quantification (D) of LC3B and p62 in uninfected or S. aureus-infected BMDMs (MOI = 10) treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) + MTK458 (50 μM). n = 5 biological independent experiments. E, F Western blot analysis (E) and quantification (F) of LC3B and p62 i/n S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) in combination with MTK458 at the indicated concentrations (5, 10, 25, and 50 μM). n = 5 biological independent experiments. G–I Representative fluorescence images (G) and quantification (H, I) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. H, MitoTracker-LysoTracker overlap ratios. I, Pearson’s correlation coefficients. Scale bar, 50 μm. n = 5/group. J, K Representative fluorescence images (J) and quantification (K) of JC-1 staining in BMDMs from the indicated groups and K Ratio of JC-1 aggregates to JC-1 monomers. Scale bar, 50 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. Exogenous Mn2+ inhibits mitophagy in Staphylococcus aureus (S. aureus)-infected bone marrow-derived macrophages (BMDMs) via the PINK1-Parkin pathway. A, B Western blot analysis (A) and densitometric quantification (B) of PINK1-Parkin pathway-related proteins in BMDMs that were uninfected or infected with S. aureus (MOI = 10) and treated with or without Mn2+ (100 μM). n = 5 biological independent experiments. C, D Western blot analysis (C) and quantification (D) of LC3B and p62 in uninfected or S. aureus-infected BMDMs (MOI = 10) treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) + MTK458 (50 μM). n = 5 biological independent experiments. E, F Western blot analysis (E) and quantification (F) of LC3B and p62 i/n S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or Mn2+ (100 μM) in combination with MTK458 at the indicated concentrations (5, 10, 25, and 50 μM). n = 5 biological independent experiments. G–I Representative fluorescence images (G) and quantification (H, I) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. H, MitoTracker-LysoTracker overlap ratios. I, Pearson’s correlation coefficients. Scale bar, 50 μm. n = 5/group. J, K Representative fluorescence images (J) and quantification (K) of JC-1 staining in BMDMs from the indicated groups and K Ratio of JC-1 aggregates to JC-1 monomers. Scale bar, 50 μm. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. Mitochondrial protein Sirt3 plays a central role in Mn2+-inhibited mitophagy Although we have delineated the signaling pathway responsible for exogenous Mn2+-mediated mitophagy suppression in S. aureus-infected BMDMs, the molecular target of Mn2+ remains undefined. To identify candidate mediators, proteomic profiling was conducted on in vitro-cultured BMDMs across three experimental groups: uninfected controls, S. aureus-infected cells, and infected cells with Mn2+ treatment. Subcellular localization analysis revealed that differentially expressed proteins (DEPs) predominantly localized to mitochondria across comparisons (Fig. 5A). We thus filtered out mitochondrion-related DEPs (Figure S5A), which clustered into five expression patterns by Mfuzz analysis (Figure S5B). To extract biological themes specifically associated with Mn2+ treatment under infection, we compared Mn2+-upregulated versus Mn2+-downregulated mitochondrial DEP clusters (Clusters 1–2 vs 3–5). GO enrichment revealed that Mn2+-upregulated DEPs were significantly associated with superoxide-related pathways (Fig. 5B), whereas downregulated DEPs were enriched in reactive oxygen species metabolic process, mitochondrial ATP synthesis-coupled electron transport regulation and oxidative phosphorylation (Fig. 5C). Inspection of the ROS metabolic category indicated broad suppression of enzymes involved in ROS catabolism and scavenging (Figure S6). These proteomic signatures are consistent with the mtROS accumulation observed above and suggest that Mn2+ also induces substantial remodeling of mitochondrial energy metabolism.Fig. 5The mitochondrial protein Sirt3 plays a central role in Mn2+-mediated inhibition of mitophagy.A–C Proteomic profiling of uninfected bone marrow-derived macrophages (BMDMs) (Blank), Staphylococcus aureus (S. aureus)-infected BMDMs (Control), and S. aureus-infected BMDMs treated with Mn2+ (100 μM) (Mn2+). A, Subcellular localization analysis of differentially expressed proteins (DEPs). B, C GO biological process enrichment of mitochondria-related DEPs. D–G Comparative proteomic analyses between Control and Mn2+ groups. D, E Gene set enrichment analysis (GSEA) of indicated pathways. F Venn diagram showing overlap of DEPs across specified categories. G Protein–protein interaction (PPI) network analysis highlighting candidate regulators. H, I Representative immunofluorescence images (H) and quantification (I) of Sirt3 (green) and mitochondria (MitoTracker, red) in BMDMs from the indicated groups. Scale bar, 50 μm. n = 5/group. J–L qPCR analysis of pro-inflammatory cytokine transcripts (Tnf-α, Il-6, Il-1β) in uninfected BMDMs and S. aureus-infected BMDMs treated with Mn2+ and/or 3-TYP (as indicated). n = 5 biological independent experiments. M, N Western blot analysis (M) and quantification (N) of proteins in the PINK1-Parkin-dependent mitophagy pathway in BMDMs from the indicated groups. n = 3 biological independent experiments. O, P Flow cytometry assessment (O) and quantification (P) of mitochondrial ROS (mtROS) in BMDMs from the indicated groups. n = 5/group. Q, R Representative images (Q) and quantification (R) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or 3-TYP (50 μM). n = 5 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. The mitochondrial protein Sirt3 plays a central role in Mn2+-mediated inhibition of mitophagy. A–C Proteomic profiling of uninfected bone marrow-derived macrophages (BMDMs) (Blank), Staphylococcus aureus (S. aureus)-infected BMDMs (Control), and S. aureus-infected BMDMs treated with Mn2+ (100 μM) (Mn2+). A, Subcellular localization analysis of differentially expressed proteins (DEPs). B, C GO biological process enrichment of mitochondria-related DEPs. D–G Comparative proteomic analyses between Control and Mn2+ groups. D, E Gene set enrichment analysis (GSEA) of indicated pathways. F Venn diagram showing overlap of DEPs across specified categories. G Protein–protein interaction (PPI) network analysis highlighting candidate regulators. H, I Representative immunofluorescence images (H) and quantification (I) of Sirt3 (green) and mitochondria (MitoTracker, red) in BMDMs from the indicated groups. Scale bar, 50 μm. n = 5/group. J–L qPCR analysis of pro-inflammatory cytokine transcripts (Tnf-α, Il-6, Il-1β) in uninfected BMDMs and S. aureus-infected BMDMs treated with Mn2+ and/or 3-TYP (as indicated). n = 5 biological independent experiments. M, N Western blot analysis (M) and quantification (N) of proteins in the PINK1-Parkin-dependent mitophagy pathway in BMDMs from the indicated groups. n = 3 biological independent experiments. O, P Flow cytometry assessment (O) and quantification (P) of mitochondrial ROS (mtROS) in BMDMs from the indicated groups. n = 5/group. Q, R Representative images (Q) and quantification (R) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), or 3-TYP (50 μM). n = 5 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. We validated these metabolic features experimentally. Seahorse analysis showed increased glycolytic activity in Mn2+-treated infected BMDMs (Figure S7), and electron transport chain (ETC) analyses further supported reduced assembly and activity of ETC components (Figure S8). This pattern is consistent with metabolic reprogramming in activated macrophages, which is typically characterized by decreased oxygen consumption rate (OCR) and increased extracellular acidification rate (ECAR), and has also been reported in mitophagy-inhibited BMDMs20. We therefore performed GSEA focusing on mitochondrial function and cellular respiration, comparing proteomes of infected BMDMs with or without Mn2+. Mn2+ treatment was found to be associated with suppression of mitochondrial programs, including mitochondrial gene expression, respiratory chain complex assembly, and aerobic respiration (Fig. 5D, E), supporting disruption of mitochondrial energy metabolism and pointing to potential upstream regulators. To prioritize candidate targets, we intersected DEPs from GO cellular component “mitochondrion” (Figure S5F), GO molecular function “transition metal ion binding” (Figure S5G), and GO biological process “aerobic respiration” (Fig. 5D), which yielded two candidates: Sirt3 and Pde2a (Fig. 5F). Following protein-protein interaction (PPI) analysis also highlighted Sirt3 as a central module within the immune regulatory network (Fig. 5G). With volcano plot and box plot displaying the repressed expression of Sirt3 (Figure S5H, I), western blot and immunofluorescent staining further validated the Mn2+-mediated dose-dependent suppression (Figure S5J, K) and the mitochondrial localization of Sirt3 (Fig. 5H–I). Therefore, the mitochondrial protein of Sirt3 is highly implicated as a key mediator of Mn2+-driven mitochondrial metabolic interference. Sirt3 is an NAD+-dependent deacetylase in mitochondria that regulates mitochondrial redox homeostasis and has been widely identified as a positive regulator of mitophagy. Specifically, it activates PINK1/Parkin-mediated mitophagy either directly, by enhancing PINK1 stability, or indirectly, by modulating upstream transcription factors such as FoxO3a40,50. However, its role in macrophage antibacterial defense remains incompletely defined. Given the Mn2+-induced Sirt3 suppression, we next investigated the effect of pharmacological Sirt3 inhibition on S. aureus-infected BMDMs using 3-TYP. Remarkably, 3-TYP administration alone recapitulated multiple Mn2+-induced phenotypes, including increased inflammatory gene expression (Fig. 5J–L), suppressed PINK1-Parkin-mediated mitophagy (Fig. 5M, N), elevated mtROS generation (Fig. 5O, P), and enhanced bactericidal capacity (Fig. 5Q, R). These parallel outcomes thus suggest a functional link between Sirt3 repression and immune potentiation, identifying Sirt3 as a probable molecular target through which exogenous Mn2+ exerts the immunomodulatory effects in S. aureus-infected BMDMs. Overexpression of Sirt3 diminished the immunomodulatory effect of exogenous Mn2+ To confirm the role of Sirt3 in Mn2+-mediated immunomodulation in S. aureus-infected BMDMs, both pharmacological and genetic overexpression approaches were employed to establish in vitro cell models, in which the overexpression efficiency via Sirt3 activator AR-C17 and transfection of mouse Sirt3 overexpression plasmid were measured by western blot and qPCR (Figure S9). We initially assessed PINK1-Parkin signaling and mitophagy markers. Western blot showed that Sirt3 overexpression counteracted Mn2+-induced suppression of PINK1-Parkin axis, concomitant with increased LC3B II/I ratios and alleviated p62 accumulation (Fig. 6A, B). Consistently, mitophagy fluorescent staining further supported this finding, as reflected by rebound Pearson’s correlation coefficients (PCC) and overlap ratio for MitoTracker and LysoTracker signals in Sirt3-overexpression BMDMs (Fig. 6C–E), indicating that elevating Sirt3 reverses Mn2+-mediated mitophagy inhibition. We next assessed downstream functional consequences. Sirt3 overexpression abolished the Mn2+-associated increase in mtROS (Fig. 6F, G) and concomitantly attenuated Mn2+-enhanced bacterial killing (Fig. 6H, I). In addition, the expression levels of proinflammatory factors were also observed to decrease, exhibiting a weakened immune response by Sirt3 overexpression in comparison to Mn2+ treatment alone (Fig. 6J-L). Together, these coordinated results establish the pivotal role of Sirt3 in Mn2+-mediated immunomodulation on S. aureus-infected BMDMs.Fig. 6Sirt3 overexpression diminishes the immunomodulatory effects of exogenous Mn2+.A, B Western blot analysis (A) and quantification (B) of proteins in the PINK1/Parkin-dependent mitophagy pathway in uninfected bone marrow-derived macrophages (BMDMs), Staphylococcus aureus (S. aureus)-infected BMDMs, and S. aureus-infected BMDMs treated with Mn2+ (100 μM), Mn2+ (100 μM) + AR-C17 (15 μM), or Mn2+ (100 μM) in combination with a Sirt3-overexpressing plasmid (as indicated). n = 5 biological independent experiments. C–E Representative fluorescence images (C) and quantification (D, E) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. D Pearson’s correlation coefficients. E MitoTracker-LysoTracker overlap rates. Scale bar, 50 μm. n = 5/group. F, G Representative flow cytometry plots (F) and quantification (G) of mitochondrial ROS (mtROS) in BMDMs from the indicated groups. n = 5/group. H, I Representative plate-based bacterial killing assay images (H) and quantification (I) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), Mn2+ (100 μM) + AR-C17 (15 μM), or Mn2+ (100 μM) plus Sirt3-overexpressing plasmid. n = 5 biological independent experiments. J–L qPCR analysis of inflammatory cytokine transcripts (Tnf-α, Il-6, Il-1β) in BMDMs from the indicated groups. n = 5 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. Sirt3 overexpression diminishes the immunomodulatory effects of exogenous Mn2+. A, B Western blot analysis (A) and quantification (B) of proteins in the PINK1/Parkin-dependent mitophagy pathway in uninfected bone marrow-derived macrophages (BMDMs), Staphylococcus aureus (S. aureus)-infected BMDMs, and S. aureus-infected BMDMs treated with Mn2+ (100 μM), Mn2+ (100 μM) + AR-C17 (15 μM), or Mn2+ (100 μM) in combination with a Sirt3-overexpressing plasmid (as indicated). n = 5 biological independent experiments. C–E Representative fluorescence images (C) and quantification (D, E) of MitoTracker and LysoTracker co-staining in BMDMs from the indicated groups. D Pearson’s correlation coefficients. E MitoTracker-LysoTracker overlap rates. Scale bar, 50 μm. n = 5/group. F, G Representative flow cytometry plots (F) and quantification (G) of mitochondrial ROS (mtROS) in BMDMs from the indicated groups. n = 5/group. H, I Representative plate-based bacterial killing assay images (H) and quantification (I) of bacterial burden in S. aureus-infected BMDMs treated with PBS, Mn2+ (100 μM), Mn2+ (100 μM) + AR-C17 (15 μM), or Mn2+ (100 μM) plus Sirt3-overexpressing plasmid. n = 5 biological independent experiments. J–L qPCR analysis of inflammatory cytokine transcripts (Tnf-α, Il-6, Il-1β) in BMDMs from the indicated groups. n = 5 biological independent experiments. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data and uncropped Western blot images are provided as a Source Data file. Thus far, it is demonstrated that the exogenous Mn2+ efficiently inhibits the PINK1-Parkin-mediated mitophagy via repressing the mitochondrial protein Sirt3, thus intensively augmenting the production of mtROS and consequently enhancing the bactericidal capacity of S. aureus-infected BMDMs. Based on this immunomodulatory mechanism, it is of great potential to propose a Mn2+-based metalloimmunotherapeutical strategy for SIOM treatment. Developing a Mn2+-based nano-system with inflammation-targeting and intracellular delivery abilities for SIOM treatment Building on our mechanistic findings that Mn2+ enhances macrophage bactericidal activity during S. aureus infection, we sought to translate this concept into a metalloimmunotherapeutic strategy for SIOM. For in vivo application, an effective system should enable inflammatory-site targeting while delivering Mn2+ intracellularly to macrophages. To achieve this, we constructed a macrophage membrane-coated MnO-loaded ZIF-8 (denoted as MZM) nano-system. In this design, manganese oxide (MnO) nanoparticles serve as the Mn2+ source, Zeolitic imidazolate framework-8 (ZIF-8) stabilizes the loaded MnO NPs and improves the payload efficiency (denoted as MZ), and the macrophage membrane coating confers lesion-specific targeting and intracellular delivery capabilities (Fig. 7A).Fig. 7Development of a Mn2+-based nanosystem with inflammation-targeting and intracellular delivery capabilities for Staphylococcus aureus-induced osteomyelitis (SIOM) therapy.A Schematic illustration of the synthesis and assembly of the macrophage membrane-coated MnO-loaded ZIF-8 (MZM) nano-system. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/7ywb4cd. B, C Representative transmission electron microscopy (TEM) images. Scale bar, 500 nm. (B) and high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) images with energy-dispersive X-ray spectroscopy (EDS) elemental mapping (C) of MZM. D High-resolution Mn 2p X-ray photoelectron spectroscopy (XPS) spectrum of MZ nanoparticles (MZ NPs). E, F Dynamic light scattering (DLS) particle size distributions (E) and zeta potentials (F) of MnO NPs, ZIF-8 NPs, MZ NPs, and MZM. G SDS-PAGE analysis of protein profiles from MZ NPs, macrophage membranes, and MZM. H, I Representative fluorescence images (H) and quantification (I) of cellular uptake of MZ NPs and MZM by RAW264.7 cells under resting conditions or following S. aureus activation at the indicated time points (1, 2, and 4 h). Scale bar, 20 μm. n = 5/group. J Ex vivo fluorescence imaging of major organs at 1 h after intravenous (tail vein) administration of MZM. K In vivo fluorescence imaging of MZ NPs and MZM at the indicated time points post-injection in uninfected mice and in the SIOM model. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Development of a Mn2+-based nanosystem with inflammation-targeting and intracellular delivery capabilities for Staphylococcus aureus-induced osteomyelitis (SIOM) therapy. A Schematic illustration of the synthesis and assembly of the macrophage membrane-coated MnO-loaded ZIF-8 (MZM) nano-system. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/7ywb4cd. B, C Representative transmission electron microscopy (TEM) images. Scale bar, 500 nm. (B) and high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) images with energy-dispersive X-ray spectroscopy (EDS) elemental mapping (C) of MZM. D High-resolution Mn 2p X-ray photoelectron spectroscopy (XPS) spectrum of MZ nanoparticles (MZ NPs). E, F Dynamic light scattering (DLS) particle size distributions (E) and zeta potentials (F) of MnO NPs, ZIF-8 NPs, MZ NPs, and MZM. G SDS-PAGE analysis of protein profiles from MZ NPs, macrophage membranes, and MZM. H, I Representative fluorescence images (H) and quantification (I) of cellular uptake of MZ NPs and MZM by RAW264.7 cells under resting conditions or following S. aureus activation at the indicated time points (1, 2, and 4 h). Scale bar, 20 μm. n = 5/group. J Ex vivo fluorescence imaging of major organs at 1 h after intravenous (tail vein) administration of MZM. K In vivo fluorescence imaging of MZ NPs and MZM at the indicated time points post-injection in uninfected mice and in the SIOM model. n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Characterization of MZM was initially conducted. The representative TEM images revealed the roughly spherical morphology of MZM with an average diameter of 385 ± 5 nm (Fig. 7B). High-angle annular dark field scanning transmission electron microscopy (HAADF-STEM) images clearly showed abundant MnO NPs loaded on the surface of MZ (Figure S10C), and energy dispersive X-ray (EDX) elemental mapping confirmed uniform distribution of C, N, Zn, O, and Mn in MZ NPs (Figure S10F), with additional P detected in MZM (Fig. 7C), corresponding to the biomimetic membrane coating. X-ray photoelectron spectroscopy (XPS) verified the dominant Mn2+ valence state (Fig. 7D), which is essential for immunomodulatory functionality. Fourier transform infrared (FT-IR) spectra identified characteristic MnO and ZIF-8 absorption bands in MZ (Figure S10I), while X-ray diffraction (XRD) patterns demonstrated preserved ZIF-8 crystal structure post-MnO loading (Figure S10J). Dynamic light scattering (DLS) then revealed the hydrodynamic diameters of MZM to be 437.5 ± 3 nm, with the zeta potential of MZM measured as −7.66 mV due to the macrophage-membrane coating (Fig. 7E, F). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS−PAGE) protein profiles confirmed the retention of RAW264.7 macrophage membrane proteins in MZM (Fig. 7G), ensuring the chemotactic effect-induced inflammation targeting capability. The in vitro Mn2+ ions release behavior was then measured under different pH values (7.4 and 5.4) by inductively coupled plasma-mass spectrometry (ICP-MS). MZ NPs displayed rapid and extensive Mn2+ release under acidic environment, while MZM demonstrated negligible ion release across both conditions (Figure S10K), together exhibiting the good pH-responsive property of MZ and excellent stability bestowed by macrophage-membrane coating. Herein, these collective results validate the successful synthesis of MZM nano-system. We then evaluated cellular uptake using FITC-labeled MZ nanoparticles (F-MZ) and FITC-labeled MZM (M-F-MZ) in resting versus S. aureus-activated RAW264.7 macrophages. As shown in Fig. 7H and I, F-MZ NPs were gradually engulfed by resting macrophages with increasing colocalization of F-MZ and lysosomes, whereas negligible FITC signal was observed in macrophages incubated with M-F-MZ, suggesting the effective evasion from macrophage clearance by biomimetic membrane decoration. By contrast, S. aureus-activated macrophages exhibited rapid and extensive accumulation of M-F-MZ, suggesting the efficient cellular uptake by inflammatory macrophages. To evaluate in vivo targeting to infected medullary cavities, we labeled MZ and MZM with Cy7 (Cy7-MZ and M-Cy7-MZ) and injected them via the tail vein into infected and non-infected mice on day 4 post-surgery. Ex vivo imaging showed clear fluorescent signals within the infected femurs as early as 1 h post-injection, whereas no fluorescent signal was detected in the contralateral femur (Fig. 7J). Dynamic monitoring of fluorescent signals was continually performed through small animal in vivo imaging spectrum (IVIS). Signal intensity at the infection site increased rapidly and followed a time-dependent pattern, with initial accumulation (1–6 h), peak intensity (6–12 h), and subsequent clearance (24–48 h) (Fig. 7K). Together, these results demonstrate that MZM possesses efficient cellular uptake by activated macrophages and inflammation-site targeting abilities, satisfying the requirements for precise immunomodulation in vivo. Biocompatibility, Mn2+retention and potential negative effects of MZM nano-system The biocompatibility of MZM nano-system was then evaluated. In vitro, CCK-8 assays showed minimal cytotoxicity, with viability of BMDMs and primary mouse-derived bone marrow mesenchymal stem cells (BMSCs) remaining above 80% after 72 h of exposure to high Mn concentrations (200–400 μM) (Figure S11). Hemolytic analysis further indicated good hemocompatibility, with RBC hemolysis <5% at 100 μM, meeting the ASTM E2524-08 criterion (Figure S11). In vivo, systemic toxicity was assessed by histopathology and blood analyses. Hematoxylin and eosin (H&E) staining of major organs (heart, liver, spleen, lung, and kidney) collected at day 21 revealed no overt pathological lesions or tissue damage (Figure S11). Consistently, blood routine tests (BRT) and serum biochemistry analysis (ALT, AST, and Cr) showed no significant differences between MZM-treated mice and healthy controls (Figure S12). To examine systemic exposure and potential retention, we quantified Mn distribution after administration. Compared with free Mn2+ injection, which caused systemic elevation, MZM administration exhibited a rapid and localized Mn increase predominantly in the infected femur within 48 h post-injection. And although continuous dosing (up to day 14) maintained elevated Mn levels in the target bone in MZM group, Mn levels in all tissues returned to baseline by day 21 (7 days post-cessation), indicating that MZM possesses excellent bone-targeting capability without the risk of long-term systemic Mn retention (Figure S13). Considering the growth-promoting effect of Mn2+ on bacteria33, we further assessed the potential risk of MZM in vivo, with distinct outcomes observed according to the Mn2+ delivery form. In systemic S. aureus infection model, free Mn2+ administration increased mortality, consistent with the risks of systemic Mn exposure34, while MZM treatment proved safe and reduced bacterial burdens in major organs (Figure S14). Similarly, in the SIOM model, MZM significantly improved infection control, whereas free Mn2+ tended to aggravate local severity (Figure S15). Flow cytometry further revealed that MZM favorably modulated the immune microenvironment, increasing macrophage proportions and reducing neutrophils, while free Mn2+ was associated with an impaired immune response (Figure S16). These findings suggest that targeted delivery via MZM can effectively mitigate the systemic risks observed with free Mn2+ while achieving therapeutic benefit. MZM nano-system precisely represses Sirt3 and efficiently enhances the bactericidal function of macrophages in SIOM mice To assess the in vivo immunomodulatory efficacy of MZM, we employed the implant-associated osteomyelitis mouse model and, as a mechanistic rescue approach, generated macrophage membrane-coated AR-C17 nanoparticles (MA) to activate Sirt3 in vivo (Figure S17). S. aureus-infected mice were randomized into four groups receiving tail vein injections every other day: (1) PBS, (2) MZM, (3) MZM+vehicle (MV), or (4) MZM + MA. Non-infected mice served as a blank control. Femurs from the operated side were harvested on day 14 post-surgery (Fig. 8A).Fig. 8The macrophage membrane-coated MnO-loaded ZIF-8 (MZM) nano-system suppresses Sirt3 and enhances macrophage bactericidal activity in Staphylococcus aureus-induced osteomyelitis (SIOM) mice.A Experimental scheme for SIOM model establishment, treatment administration, and sample collection. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/eb24snq. B, C Representative immunofluorescence images (B) and quantification (C) of F4/80 (macrophages, red) and Sirt3 (green) co-staining in femoral sections from uninfected mice, SIOM mice, and SIOM mice treated intravenously (tail vein) with MZM or MZM + MA (as indicated). Scale bar, 50 μm. n = 5/group. D, E Representative immunofluorescence images (D) and quantification (E) of F4/80 (red) and PINK1 (green) co-staining in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. F, G Flow cytometry analysis (F) and quantification (G) of mitophagy in femoral macrophages from the indicated groups. n = 5/group. H, I Representative immunofluorescence images (H) and quantification (I) of F4/80 (red) and S. aureus (green) co-localization in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. J, K Representative haematoxylin and eosin (H&E) staining images (J) and histopathological scores (K) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. The macrophage membrane-coated MnO-loaded ZIF-8 (MZM) nano-system suppresses Sirt3 and enhances macrophage bactericidal activity in Staphylococcus aureus-induced osteomyelitis (SIOM) mice. A Experimental scheme for SIOM model establishment, treatment administration, and sample collection. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/eb24snq. B, C Representative immunofluorescence images (B) and quantification (C) of F4/80 (macrophages, red) and Sirt3 (green) co-staining in femoral sections from uninfected mice, SIOM mice, and SIOM mice treated intravenously (tail vein) with MZM or MZM + MA (as indicated). Scale bar, 50 μm. n = 5/group. D, E Representative immunofluorescence images (D) and quantification (E) of F4/80 (red) and PINK1 (green) co-staining in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. F, G Flow cytometry analysis (F) and quantification (G) of mitophagy in femoral macrophages from the indicated groups. n = 5/group. H, I Representative immunofluorescence images (H) and quantification (I) of F4/80 (red) and S. aureus (green) co-localization in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. J, K Representative haematoxylin and eosin (H&E) staining images (J) and histopathological scores (K) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Immunofluorescence staining of femoral sections revealed significant Sirt3 downregulation in F4/80+ macrophages around the abscess lesion following MZM treatment, while co-administration of MA markedly mitigated this decrease (Fig. 8B, C). Parallel assessment demonstrated MZM-induced inhibition of PINK1 expression in F4/80+ macrophages, which was counteracted by Sirt3 activation via MA co-administration (Fig. 8D, E). These results indicated that MZM precisely repressed the Sirt3 expression in macrophages within the infected medullary cavity, along with the inhibited PINK1-parkin signaling pathway. Flow cytometry analysis using Mitophagy Dye further confirmed the mitophagy inhibition of macrophages in the MZM-treated group, which was significantly attenuated in the MZM + MA group (Fig. 8F, G, Figure S18). To evaluate macrophage bactericidal activity in situ, we then co-stained the F4/80 and S. aureus in femoral sections. The immunofluorescent staining displayed an obviously decreased colocalization of F4/80+ macrophages and S. aureus in the MZM group compared to the control group, whereas MA coadministration exhibited an attenuation (Fig. 8H, I). Histological analysis further showed markedly improved tissue pathology in the MZM-treated group, while MA co-administration exacerbated the condition with rebound histological scores (Fig. 8J, K). Collectively, these results indicate that MZM precisely represses the expression of Sirt3 in macrophages within the infected medullary cavity, thus notably enhances the cellular bactericidal activity in SIOM. MZM nano-system achieved satisfactory efficacy in treating SIOM The therapeutic efficacy of MZM nano-system in treating SIOM was subsequently evaluated. SIOM mice were randomized to receive PBS (control) or MZM via tail-vein injection every other day; non-infected mice served as blank controls. Implanted screws and operated femurs were harvested on day 14 post-surgery. Scanning electron microscope (SEM) was utilized to detect the bacterial colonization on the surfaces of retrieved screws. As shown in Fig. 9A, massive S. aureus cells were adhering on the surfaces of implanted screws from the control group, while negligible bacteria were detected in the MZM group. Immunofluorescent staining of S. aureus consistently revealed a dramatical reduction in S. aureus+ area within the infected medullary cavity after MZM treatment (Fig. 9B, C), indicating substantially reduced bacterial burden. Histological assessment through H&E staining then showed marked improvement in the MZM group with reduced abscess formation and recovered trabecular structures, whereas the control group displayed extensive abscess spread and fibroblast-like cells aggregation, along with exhausted trabecular bone and massive reactive bone formation (Fig. 9D, E). Micro-CT analysis further corroborated these observations, displaying notable alleviation of bone destruction and reactive cortical bone formation in the MZM group, while the control group exhibited pronounced cortical bone defects and bone loss around the femoral nail canal (Fig. 9F–H). Quantitative analysis of trabecular bone microstructure confirmed the improvements in MZM-treated mice, with increased bone mineral density (BMD), bone volume fraction (BV/TV), trabecular number (Tb.N) and thickness (Tb.th), together with reduced trabecular separation (Tb.Sp) (Fig. 9I–M). Collectively, these results demonstrate that MZM achieves potent therapeutic outcomes in SIOM by day 14 in SIOM.Fig. 9The macrophage membrane-coated MnO-loaded ZIF-8(MZM) nano-system confers therapeutic benefit in Staphylococcus aureus-induced osteomyelitis (SIOM).A Representative scanning electron microscopy (SEM) images of retrieved femoral implants from uninfected mice, SIOM mice, and MZM-treated SIOM mice at day 14 post-operation. Scale bar, 200 μm, 40 μm, 10 μm. n = 5/group. B, C Representative immunofluorescence images (B) and quantification (C) of S. aureus staining in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. D, E Representative haematoxylin and eosin (H&E) staining images (D) and histological scores (E) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. F–M Micro-computed tomography (micro-CT) assessment of femurs from the indicated groups. F, Representative three-dimensional reconstructions and coronal images. G, H Quantification of cortical bone loss (G) and reactive bone formation (H). I–M Quantification of bone mineral density (BMD, I), bone volume fraction (BV/TV, J), trabecular number (Tb.N, K), trabecular thickness (Tb.Th, L), and trabecular separation (Tb.Sp, M). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. The macrophage membrane-coated MnO-loaded ZIF-8(MZM) nano-system confers therapeutic benefit in Staphylococcus aureus-induced osteomyelitis (SIOM). A Representative scanning electron microscopy (SEM) images of retrieved femoral implants from uninfected mice, SIOM mice, and MZM-treated SIOM mice at day 14 post-operation. Scale bar, 200 μm, 40 μm, 10 μm. n = 5/group. B, C Representative immunofluorescence images (B) and quantification (C) of S. aureus staining in femoral sections from the indicated groups. Scale bar, 50 μm. n = 5/group. D, E Representative haematoxylin and eosin (H&E) staining images (D) and histological scores (E) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. F–M Micro-computed tomography (micro-CT) assessment of femurs from the indicated groups. F, Representative three-dimensional reconstructions and coronal images. G, H Quantification of cortical bone loss (G) and reactive bone formation (H). I–M Quantification of bone mineral density (BMD, I), bone volume fraction (BV/TV, J), trabecular number (Tb.N, K), trabecular thickness (Tb.Th, L), and trabecular separation (Tb.Sp, M). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. To examine durability of therapeutic benefit, mice were followed for an additional 7 days after the treatment phase, and operated femurs were collected on day 21 (Fig. 10A). Immunofluorescence staining demonstrated progressive expansion of S. aureus-positive areas in the control group, whereas MZM-treated mice maintained minimal bacterial burden (Fig. 10B, C). Histological analysis revealed near-normal bone architecture, with minimal abscess formation and restored trabecular structures in the MZM group, while femurs from the control group displayed exacerbated bone destruction as osteomyelitis progressed (Fig. 10D, E). Three-dimensional micro-CT reconstruction consistently revealed this disparity, showing severe deformity and bone loss in the control group compared with substantially preserved femoral architecture in the MZM group (Fig. 10F–M). Herein, these results indicate that MZM confers durable therapeutic benefits in SIOM.Fig. 10Macrophage membrane-coated MnO-loaded ZIF-8(MZM) treatment shows sustained medium-to-long-term therapeutic efficacy in Staphylococcus aureus-induced osteomyelitis (SIOM) mice.A Experimental scheme for evaluating the medium-to-long-term therapeutic efficacy of MZM in the SIOM model. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/v0mxq2g.B, C Representative immunofluorescence images (B) and quantification (C) of S. aureus staining in femoral sections from uninfected mice, SIOM mice, and MZM-treated SIOM mice at day 21 post-operation. Scale bar, 50 μm. n = 5/group. D, E Representative haematoxylin and eosin (H&E) staining images (D) and histopathological scores (E) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. F-M Micro-computed tomography (micro-CT) assessment of femurs from the indicated groups at day 21 post-operation. F, Representative three-dimensional reconstructions and coronal images. G, H Quantification of cortical bone loss (G) and reactive bone formation (H). I–M Quantification of bone mineral density (BMD, I), bone volume fraction (BV/TV, J), trabecular thickness (Tb.Th, K), trabecular number (Tb.N, L), and trabecular separation (Tb.Sp, M). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Macrophage membrane-coated MnO-loaded ZIF-8(MZM) treatment shows sustained medium-to-long-term therapeutic efficacy in Staphylococcus aureus-induced osteomyelitis (SIOM) mice. A Experimental scheme for evaluating the medium-to-long-term therapeutic efficacy of MZM in the SIOM model. Graphic was created in BioRender. Kwan, O. (2026) https://BioRender.com/v0mxq2g.B, C Representative immunofluorescence images (B) and quantification (C) of S. aureus staining in femoral sections from uninfected mice, SIOM mice, and MZM-treated SIOM mice at day 21 post-operation. Scale bar, 50 μm. n = 5/group. D, E Representative haematoxylin and eosin (H&E) staining images (D) and histopathological scores (E) of femurs from the indicated groups. Scale bars, 1 mm (overview), 250 μm (mid magnification), and 100 μm (high magnification). n = 5/group. F-M Micro-computed tomography (micro-CT) assessment of femurs from the indicated groups at day 21 post-operation. F, Representative three-dimensional reconstructions and coronal images. G, H Quantification of cortical bone loss (G) and reactive bone formation (H). I–M Quantification of bone mineral density (BMD, I), bone volume fraction (BV/TV, J), trabecular thickness (Tb.Th, K), trabecular number (Tb.N, L), and trabecular separation (Tb.Sp, M). n = 5/group. Data are presented as mean ± SEM. Statistical significance was assessed using two-tailed one-way ANOVA with Turkey’s post hoc test. Statistical significance is indicated in the figure with corresponding p values. Source data are provided as a Source Data file. Given that the SIOM mice model involves concomitant gentamicin administration, it is critical to determine whether the observed therapeutic efficacy of MZM arises from immunomodulation or from potentiating the antibiotic’s activity. To address this, an in vitro checkerboard assay was performed. The results revealed no reduction in the MIC of gentamicin upon Mn2+ addition, arguing against direct antibiotic potentiation (Figure S19). We then conducted an additional in vivo experiment including groups without gentamicin treatment. Two-way ANOVA revealed a strong main effect of MZM in reducing bacterial burden, and MZM significantly controlled infection in the absence of gentamicin (Figure S20). These findings support that MZM provides an antibiotic-independent contribution to therapeutic efficacy, which is exerted via a host-directed immunomodulatory mechanism. Discussion Treatment of SIOM remains challenging in orthopedic clinical practice due to the diverse immune evasion mechanisms of S. aureus5,51. Among them, intracellular infection within macrophages represents one of the major strategies9,52,53. By impairing the bactericidal function of macrophages, S. aureus converts these first-line immune defense cells into the primary reservoir of bacterial colonization, which ultimately leads to bacterial dissemination and recurrent infections6. Accordingly, enhancing macrophage bactericidal activity is a promising immunomodulatory strategy in treating SIOM. With this aim, our present study began with the attenuated bactericidal function of macrophages in SIOM and brought in the immunostimulatory role of Mn2+ to investigate the potential therapeutic effect. Notably, we demonstrate a distinct immunomodulatory mechanism of Mn2+ in S. aureus-infected macrophages, wherein exogenous Mn2+ inhibits S. aureus-induced mitophagy by repressing the mitochondria protein of Sirt3, thereby augmenting mtROS production to enhance the bactericidal function. Leveraging this, we further develop a Mn2+-based metalloimmunotherapy with inflammation-targeting and intracellular delivery abilities for the treatment of SIOM. Recent studies have highlighted the immunosuppressive state induced by S. aureus9,25,41, in which macrophages-the essential components of host innate immune defense system-failed to efficiently exert their bactericidal activity. In macrophages, mtROS production directly contributes to bacterial clearance and host defense13, and mitophagy inhibition has been demonstrated to elevate mtROS and trigger the activation of macrophages20. However, multiple studies have noticed that S. aureus undermines this bactericidal mechanism via mitophagy induction24,49. Our previous studies have elaborated the increased mitophagy and decreased mtROS production in S. aureus-infected macrophages through distinct signaling pathways, including PD-1/PD-L1 and EGFR-MEK1/2 cascade25,26. In line with this, inhibition of mitophagy by blocking these signaling pathways significantly reduces the bacterial burden and alleviates bone destruction. These findings collectively shed light on a potential immunomodulatory strategy for the treatment of SIOM. In the present study, we targeted mitophagy-mtROS axis to present a rational strategy to enhance macrophages bactericidal function for the treatment of SIOM. The immunostimulatory role of Mn2+ has been an active topic in anti-tumor research. In bacterial infection, prior work has largely focused on manganese sequestration as a component of nutritional immunity33–35; However, the therapeutic feasibility of Mn2+ to prime host antibacterial defense has not been fully investigated. Here, we show that exogenous Mn2+ robustly enhances the bactericidal activity of S. aureus-infected macrophages. Jiang and colleagues demonstrated Mn2+-mediated immune priming in antiviral responses, showing that Mn2+ sensitizes cGAS to cytosolic dsDNA and increases STING affinity for cyclic dinucleotides, thereby promoting cGAS-STING activation29. Leveraging this, multiple groups have proposed Mn2+-based metalloimmunotherapies to reverse tumor immunosuppression30,32. Nevertheless, cGAS-STING activation alone is unlikely to fully explain our observations in S. aureus-infected macrophages. The primary downstream effects of cGAS-STING signaling-type I interferons induction via TBK1/IRF3 axis and pro-inflammatory cytokines production via NF-κB signaling mainly amplify inflammatory response, rather than directly enhancing macrophage bactericidal function54–56. Additionally, recent studies have reported that the activation of cGAS-STING signaling led to increased phagocytosis of tumor-associated macrophages (TAMs)57, whereas we did not observe significant changes on this phenotype. Thereby, there may be a more direct immunomodulatory mechanism of Mn2+ for enhancing the bactericidal activity in S. aureus-infected macrophages. Our finding that exogenous Mn2+ administration markedly augments mtROS production in S. aureus-infected macrophages is both surprising and interesting, particularly given reports that Mn2+ dampens mitochondrial electron transport chain (ETC) activity and reduces mtROS in neutrophils58. This discrepancy likely reflects fundamental differences in mitochondrial organization and ROS-generating programs between these cell types. Compared with neutrophils59–61, macrophages possess a more abundant and plastic mitochondrial network and can generate mtROS through multiple ETC-associated routes, including forward and reverse electron transport (FET and RET) and electron leak at complexes I and III20,62. In activated macrophages, mtROS production is often accompanied by reduced ETC complex assembly and activity20,63- a pattern that we also observed in Mn2+-treated macrophages (Figure S7, Figure S8). Therefore, while we emphasize Mn2+-driven mitophagy inhibition as a major contributor to mtROS accumulation during S. aureus infection, Mn2+-induced remodeling of mitochondrial metabolism may act upstream and warrants further investigation. Manganese overexposure is well known to cause neurotoxicity by disrupting mitochondrial homeostasis and promoting oxidative stress64–66. However, the precise mechanisms-particularly regarding the modulation of Mn2+ on mitophagy-remain debated. In SH-SY5Y cells, Mn2+ has been reported to induce mitophagy and exacerbate neurotoxicity, potentially through BNIP3-dependent ROS signaling67. Besides, a recent study has reported an unexpected protective effect of tolerable upper intake level of Mn2+ in SH-SY5Y cells, with mitophagy activation implicated as a contributing mechanism68. Conversely, in microglia-the resident macrophages in central nervous system (CNS)-excessive Mn2+ suppresses the PINK1/Parkin-mediated mitophagy and aggravates neuroinflammation via the mtDNA-STING pathway36. Similar Mn2+-associated mitophagy inhibition has also been reported in the SH-SY5Y cell line and primary neurons by Xu’s group69,70. These seemingly contradictory results may be attributed to the levels of Mn2+ and the basal state of cells under specific conditions. Intriguingly, our data reveal that under S. aureus infection, exogenous Mn2+ supplementation (100 μM) markedly suppresses mitophagy in BMDMs, accompanied by increased mtROS production. Time-course monitoring reveals a biphasic mtROS pattern in S. aureus-infected BMDMs, whereas Mn2+ treatment led to a sustained increase in mtROS. This may be explained by the infection-associated upregulation of mitophagy24,27,49, while this process is specifically interrupted by Mn2+. Consistent with this, we further demonstrate that the Mn2+ inhibits mitophagy by interfering with the PINK1-Parkin signaling pathway, the primary pathway of S. aureus-induced mitophagy24,49. Mechanistically, we identify the mitochondrial protein of Sirt3 as a key mediator of Mn2+-driven mitophagy suppression. Sirt3 has been implicated in diverse biological processes, including metabolic regulation, stress responses, and mitophagy38,50,71,72. Specifically, it has also been linked to antimycobacterial defense, and silencing Sirt3 is believed to drive defective host defense and excessive inflammation via increased mitochondrial oxidative stress73. Contrary to this belief, our proteomic data reveals that the repressed Sirt3 serves as a central module in Mn2+-induced remodeling of mitochondrial metabolism, thereby enhancing mtROS generation and strengthening antibacterial activity. Supporting our observation, Newcastle disease virus (NDV)-induced Sirt3 loss has been shown to drive a metabolic shift from oxidative phosphorylation toward glycolysis, characterized by decreased OCR and increased ECAR74, which is also a feature of activated macrophages20. Additionally, pharmacologic inhibition of Sirt3 with 3-TYP recapitulated Mn2+-associated immune priming, mtROS elevation, and enhanced bactericidal activity, indicating a functional link between Sirt3 repression and immune potentiation in S. aureus-infected macrophages. Conversely, Sirt3 overexpression attenuated the immunomodulatory effects of Mn2+, demonstrating that Mn2+ exerts the mitophagy inhibition effect by repressing the expression of Sirt3, thereby augmenting the mtROS production and enhancing the bactericidal function. Notably, our current data establish that exogenous Mn2+ decreases Sirt3 abundance; the upstream mechanism, whether through accelerated protein degradation or reduced protein synthesis mediated by other factors, remains to be elucidated. Building on these findings, we synthesize the MZM nano-system as a Mn2+-based metalloimmunotherapy to enhance macrophage bactericidal function in SIOM. Biomimetic membrane-targeted delivery of active ingredients has been widely used in treating various diseases75. Consistent with this rationale, MZM exhibited rapid inflammatory-site targeting in vivo and high intracellular Mn2+ delivery efficiency in vitro. Accordingly, the injection of MZM via the tail vein effectively suppressed Sirt3 in macrophages within the infected medullary cavity, leading to reduced mitophagy, enhanced cellular bactericidal activity and decreased bacterial burden. Importantly, co-administration of the additionally constructed MA nanoparticles further supported the Mn2+-driven, Sirt3-dependent immunomodulatory effect in vivo. Current immunotherapy strategies for SIOM focus on reducing the local inflammatory response, as researchers emphasize the potentially negative influence of inflammation on bone repair76–78. Contrary to this concept, our previous work highlights that, within the S. aureus-driven immunosuppressive microenvironment, timely immune-inflammatory priming is critical to prioritize bacterial clearance and ultimately enable tissue restoration. Consistent with this concept, our study demonstrates notably alleviated bone destruction following efficient bacterial eradication through MZM treatment by day 14 post-infection. Moreover, by day 21 post-infection, femurs from the MZM-treated group exhibit near-physiological architectures with negligibly detected bacterial load in medullary cavities, demonstrating the durable benefits of MZM. These findings support Mn2+-based metalloimmunotherapy as an effective strategy for SIOM. Collectively, the current study demonstrates that exogenous Mn2+ possesses a distinct immunomodulatory mechanism to enhance the bactericidal function of S. aureus-infected macrophages, which is exerted by mitochondria protein Sirt3 repression, subsequent PINK1/Parkin-mediated mitophagy inhibition, and consequent mtROS augmentation. Based on this, a Mn2+-based metalloimmunotherapeutical strategy is proposed for treating SIOM. With efficient inflammation targeting and intracellular delivery abilities, the synthesized MZM nano-system realizes precise repression of Sirt3 in macrophages within the infected medullary cavity and achieves satisfactory efficacy. In conclusion, our current work provides not only a distinct Mn2+-possessed immunomodulatory mechanism but also an effective metalloimmunotherapy for SIOM treatment, both of which merit a wider and more in-depth exploration on bacterial infectious diseases. Methods Implant-associated S. aureus osteomyelitis mouse model All experimental procedures involving mouse care and treatment were conducted in accordance with the ARRIVE Guidelines 2.0 and were approved by the Animal Welfare and Use Committee of Nanfang Hospital, Southern Medical University, ensuring compliance with ethical standards for animal research. C57BL/6 mice aged between 10 and 12 weeks were obtained from the Animal Center of Southern Medical University (Guangzhou, China). All mice were bred and maintained in the specific-pathogen-free animal facilities of Southern Medical University, with unrestricted access to food and water. The housing conditions were strictly controlled, involving a stable temperature maintained at 23 °C ± 2 °C, relative humidity fixed at 50%, and a 12-h light-dark cycle. Both male and female mice were selected for all procedures. The implant-associated S. aureus osteomyelitis mouse model was developed according to our previously described methodology with minor modifications41. Briefly, mice aged between 10 and 12 weeks were anesthetized by intraperitoneal injection of tribromoethanol at a dose of 125 mg/kg body weight. Ophthalmic forceps were then used to bluntly dissect the muscle and expose the third trochanter of the right femur. Next, a small hole was carefully drilled using a 27-gauge needle. A microliter syringe was employed to slowly inject 3 μL of either an S. aureus suspension (2 × 105 CFU/mL) or an equivalent volume of phosphate-buffered saline (PBS) into the marrow cavity, establishing infected and uninfected groups, respectively. After injection, a sterile self-tapping screw was inserted into the cortical bone through the drilled hole. Finally, the surgical incision was closed with 5–0 sutures, and postoperative gentamicin treatment (20 mg/kg, intraperitoneal injection) was administered daily to all mice. Transcriptomic analysis The raw files (GEO: GSE227521 and GSE166522) from our previous work41,42 and GSE10244445 from GEO datasets (https://www.ncbi.nlm.nih.gov) were processed using the DESeq2 R package (1.16.1). DEGs in bone between implant-associated S. aureus osteomyelitis mice and control mice on day 7 (GSE227521) and day 14 (GSE166522) after operation were analyzed. DEGs between S. aureus-infected and uninfected macrophages were analyzed. The Benjamini–Hochberg procedure was used to control the false discovery rate. Genes with an adjusted p value of less than 0.05 and | log2 (fold change) | value of more than 1 were identified as DEGs. GO enrichment analysis of identified DEGs was performed by clusterProfiler R package (3.6.2). GO terms with an adjusted p value of less than 0.05 were considered significant enrichment. CIBERSORT algorithm79 was performed using default signature gene sets (LM22) to characterize immune cell infiltration within tissue samples. Only samples with a CIBERSORT p-value < 0.05 were included for further interpretation. The GseaVis package (0.0.8) was used for GSEA analysis. The significance cutoff values were defined as follows: absolute Normalized Enrichment Score (NES) ≥ 1, p-value < 0.05, Benjamini–Hochberg false discovery rate <0.25. All data visualization was realized using online OmicShare Tools80 (GENE DENOVO, China) (https://www.omicshare.com). Bacterial culture and quantification The wild-type S. aureus strain utilized in this study was isolated from a patient diagnosed with infectious osteomyelitis. A sterile inoculating loop was employed to transfer monoclonal S. aureus colonies into fresh tryptic soy broth (TSB), which was then incubated at 37 °C with shaking at 180 rpm for approximately 16–18 h. Following incubation, bacterial cells were collected and washed twice with phosphate-buffered saline (PBS). Subsequently, the bacterial suspension was adjusted to an optical density of 0.5 at a wavelength of 600 nm, corresponding to a bacterial concentration of roughly 1 × 108 colony-forming units per milliliter (CFU/mL). Isolation and culture of bone marrow-derived macrophages (BMDMs) BMDMs were isolated from femurs and tibias of C57BL/6 mice (8–10 weeks old) following previously published protocols25. Briefly, mice were euthanized by cervical dislocation, and bone marrow cells were harvested by flushing the marrow cavities. After red blood cell removal using ACK lysis buffer, the bone marrow cells were cultured in RPMI-1640 medium supplemented with 30% L929 conditioned medium, 10% fetal bovine serum (FBS), and 1% penicillin-streptomycin. Cells were plated into cell culture plates and differentiated over a 7-day period, with medium changes performed every other day. On day 8 post-differentiation, cells were subjected to subsequent treatments and analyses. Immunofluorescence staining For immunofluorescence staining, femurs were fixed in 4% paraformaldehyde overnight, decalcified in 10% ethylenediamenetetraacetic acid (EDTA) solution for 10 days, and processed for paraffin-embedding. Four-μm-thick sections were placed on glass slides, deparaffinized, and rehydrated before antigen retrieval. Sections were washed with PBS, and permeabilized using 0.1% Triton-X100 in PBS (0.1% PBST) for 10 min. After incubation in blocking buffer (10% normal goat serum, 0.1% PBST), sections were incubated with primary antibodies in blocking buffer overnight at 4˚C. The primary antibodies used were rabbit anti-S. aureus antibody (Ab20920, Abcam, USA), rat anti-F4/80 antibody (MCA497GA, BIO-RAD, USA), rabbit anti-Sirt3 antibody (A5419, ABclonal, China), and rabbit anti-PINK1 antibody (23274-1-AP, Proteintech, China). After being washed three times, sections were stained with goat anti-rat IgG Dylight 594 (A23440, Abbkine, China), goat anti-rabbit IgG Dylight 488 (A23220, Abbkine, China) in blocking solution at room temperature for 1 h. Nuclei were counterstained with a 4′,6-diamidino-2-phenylindole (DAPI) solution (E607303-0002, BBI Life Science, Shanghai, China). For immunofluorescence labeling in cell cultures, cells were initially washed with PBS three times. For intracellular bacterial detection, cells were fixed in 4% paraformaldehyde for 10 min. After being washed in PBS and permeabilized using 0.3% Triton-X100 in PBS (0.3% PBST) for 5 min, cells were incubated in blocking buffer at room temperature for 1 h. For intracellular bacterial detection, cells were incubated with rabbit anti-S. aureus antibody (Ab20920, Abcam, USA) for 1 h at room temperature. After being washed three times, cells were incubated with anti-rabbit IgG Dylight 594 (A23420, Abbkine, China) and Phalloidin-iFluor (TM) 488 Conjugate (AAT-23115, AAT Bioquest, USA) for 1 h at room temperature. For Sirt3 and mitochondria immunofluorescence colocalization, cells were incubated in fresh medium containing MitoTracker Red CMXRos (40741ES50, Yeasen, China) at 37 °C for 1 h in dark. After fixation in 4% paraformaldehyde for 15 min, permeabilization using 0.3% Triton-X100 in PBS (0.3% PBST) and antigen blocking, cells were incubated with rabbit anti-Sirt3 antibody (A5419, ABclonal, China) in blocking buffer overnight at 4 °C. After being washed three times, cells were stained with goat anti-rabbit IgG Dylight 488 (A23220, Abbkine, China) in blocking solution at room temperature for 1 h. Hoechst 33342 was used to label nuclei. Images were captured using confocal laser microscopy (LSM980, Zeiss, Germany). Data analysis was performed with ImageJ software (V1.8.0, National Institute of Health). Mitochondrial reactive oxygen species (mtROS) detection BMDMs were isolated and seeded at a density of 8 × 105 cells/well in a confocal dish. On day 7, the culture medium was changed to RPMI-1640 supplemented with 10% FBS and 20% L929 conditioned medium without antibiotics. Afterward, mature BMDMs were stimulated with S. aureus at a MOI = 10 for 1 h, followed by an additional 1 h of incubation in fresh medium containing lysostaphin (20 μg/mL) and gentamicin (50 μg/mL) to remove extracellular bacteria. Then, cells were cultured in fresh medium for 0, 3, 6, 9, 12 h with or without exogenous Mn2+ addition at the indicated concentrations (25, 50, 100 μM). At each specific time point, the mtROS levels were detected. Mitochondrial ROS levels were detected using MitoSOX Red Mitochondrial Superoxide Indicators (M36008, Invitrogen, USA) and MitoTracker Green (C1048, Beyotime, China) via fluorescent staining and flow cytometry analysis, following manufacturer instructions, respectively. Fluorescent images were captured using confocal laser microscopy (LSM980, Zeiss, Germany). Flow cytometry was conducted on a BD LSRII flow cytometer (BD Biosciences, USA) and analyzed using FlowJo software (version 10, FlowJo, USA). Bacterial phagocytosis and killing capability To assess phagocytic capacity, BMDMs were isolated and seeded at a density of 2 × 105 cells/well in 24-well plates. On day 7, the culture medium was changed to RPMI-1640 supplemented with 10% FBS and 20% L929 conditioned medium without antibiotics. Cells in the Mn2+-treated group were pretreated for 12 h with exogenous addition of Mn2+, at the indicated concentration (25, 50, 100 μM) or an equivalent volume of PBS. Besides, cells were also pretreated according to the group assignments (Mn2+ (100 μM) + mtTEMPO (100 μM), Mn2+ (100 μM) + CCCP (20 μM), DMSO, 3-TYP (50 μM), Mn2+ (100 μM) + DMSO, Mn2+ (100 μM) + AR-C17 (15 μM), Mn2++BMDMsNC-plasmid, Mn2+ + BMDMsSirt3-plasmid). Afterwards, cells were exposed to S. aureus at a multiplicity of infection (MOI) of 10 for another 1 h. Following incubation, cells were washed with PBS, and extracellular bacteria were removed by treating cells with lysostaphin (20 μg/mL) and gentamicin (50 μg/mL). Subsequently, BMDMs were lysed using 0.1% (v/v) Triton X-100, and serial dilutions of the lysates were plated onto TSA plates for colony enumeration. To determine bactericidal activity, same treated BMDMs, following removal of extracellular bacteria, were incubated in fresh medium for an additional 12 h, with or without the addition of Mn2+ at the indicated concentration (25, 50, 100 μM). Then, cells were lysed, and lysates were serially diluted and plated onto TSA agar plates. Bacterial colonies were counted after overnight incubation at 37 °C. Real-time quantitative polymerase chain reaction (RT-qPCR) Total RNA was isolated from cells using RNAiso PLUS reagent according to the manufacturer’s guidelines. Subsequently, reverse transcription and quantitative PCR (qPCR) were carried out utilizing the Evo M-MLV RT Premix Kit (Accurate Biology, China) and the SYBR Green Premix Pro Taq HS qPCR Kit (Accurate Biology, China) on an Applied Biosystems QuantStudio 5 real-time PCR system. Gene expression levels were normalized to Actb as the internal control, and relative expression was determined by the 2−ΔΔCT method. Primer sequences used in qPCR analysis were as follows: TNF-α forward, 5′-TCTCATGCACCACCATCAAGGACT-3′ TNF-α reverse, 5′-ACCACTCTCCCTTTGCAGAACTCA-3′ IL-6 forward, 5′-CCCCAATTTCCAATGCTCTCC-3′ IL-6 reverse, 5′-CGCACTAGGTTTGCCGAGTA-3′ IL-1β forward, 5′-TCCTGTGTAATGAAAGACGGC-3′ IL-1β reverse, 5′-ACTCCACTTTGCTCTTGACTTC-3′ Sirt3 forward, 5′-CAGGCCCAATGTCACTCACT-3′ Sirt3 reverse, 5′-AATGTCGGGTTTCACAACGC-3′ Actb forward, 5′-GCTTCTTTGCAGCTCCTTCGTT-3′ Actb reverse, 5′-CGGAGCCGTTGTCGACGACC-3′ Primer sequences were designed using PrimerBank and NCBI Primer-BLAST (RefSeq) to ensure specificity, and were synthesized by Sangon Biotech, China. Transmission electron microscope (TEM) analysis of mitochondrial morphology BMDMs were isolated and seeded at a density of 2 × 106 cells/mL in 6-well plates. On day 7, the culture medium was changed to RPMI-1640 supplemented with 10% FBS and 20% L929 conditioned medium without antibiotics. Cells in the Mn2+-treated group were pretreated for 12 h with exogenous addition of Mn2+ at a concentration of 100 μM. Afterward, cells were exposed to S. aureus, uninfected cells were set as the blank group. After being treated as aforementioned protocol, cells were fixed using an adequate volume of pre-cooled electron microscope fixative solution (AS1063, ASPENbio, China) for 1 h at room temperature and were collected and transferred into 1.5 mL EP tubes. The mixtures were centrifuged and washed by electron microscope fixative solution for two to three times. The cellular pellets were stored in fresh electron microscope fixative solution at 4 °C. Cellular ultrastructural analysis was performed by Baiqiandu Biotechnology Co., Ltd. (Wuhan, China) using a transmission electron microscope (TECNAL G2 20 TWIN, FEI, USA) at an accelerating voltage of 80 kV. Data analysis was performed with ImageJ software (V1.8.0, National Institute of Health). MitoTracker/LysoTracker fluorescent staining For mitophagy measurements in BMDMs during S. aureus infection, BMDMs were isolated and seeded at a density of 8 × 105 cells/well in confocal dishes. After being infected and treated according to respective group assignments [PBS, Mn2+(100 μM), Mn2+ (100 μM) + DMSO, Mn2+(100 μM) + MTK458(100 μM), Mn2+(100 μM) + AR-C17(15 μM), Mn2++BMDMsNC-plasmid, Mn2+ + BMDMsEXPSirt3-plasmid], cells were incubated in fresh medium containing MitoTracker Green (C1048, Beyotime, China) and LysoTracker Red (C1046, Beyotime, China) at 37 °C for 30 min in the dark. Uninfected cells were set as the blank group. Hoechst 33342 was used to label nuclear. Subsequently, cells were washed three times with serum-free medium and immediately detected using a laser confocal microscopy (LSM980, Zeiss, Germany). Particle analysis and colocalization analysis were performed using ImageJ software (V1.8.0, National Institute of Health). JC-1 fluorescent staining For mitochondrial membrane potential (Δψm) measurements in BMDMs during S. aureus infection, BMDMs were isolated and seeded at a density of 8 × 105 cells/well in confocal dishes. After being infected and treated according to respective group assignments [PBS, Mn2+(100 μM), Mn2+ (100 μM) + DMSO, Mn2+(100 μM) + MTK458(100 μM)], nuclear staining was initially conducted using Hoechst 33342, considering the detection should be performed within 30 min after JC-1 (C2006, Beyotime, China) loading. Uninfected cells were set as the blank group. After medium discarded and PBS washed, cells were incubated in fresh medium supplemented with an equivalent volume of JC-1 working solution at 37 °C for 20 min in the dark. Afterward, cells were washed using JC-1 staining buffer for two times and immediately detected using a laser confocal microscopy (LSM980, Zeiss, Germany). Data analysis was performed using ImageJ software (V1.8.0, National Institute of Health). Western blotting BMDMs were isolated and seeded at a density of 2 × 106 cells/mL in 6-well plates, and were infected and treated according to respective group assignments [PBS, Mn2+(25, 50, 100 μM), Mn2+ (100 μM) + DMSO, Mn2+(100 μM) + MTK458(100 μM), Mn2+(100 μM) + AR-C17(15 μM), Mn2++BMDMsNC-plasmid, Mn2++BMDMsEXPSirt3-plasmid]. Uninfected cells were set as the blank group. Cells were lysed in ice-cold RIPA buffer supplemented with 1% phosphatase inhibitors and 1% protease inhibitors. Protein concentrations were determined using a BCA Protein Quantification Kit (20200ES76, Yeasen, China). Equal amounts of protein (20–30 μg) were separated by SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with Protein Free Rapid Blocking Buffer (PS108P, epizyme, China) for 30 min at room temperature and incubated overnight at 4 °C with primary antibodies against PINK1 (1:500, 23274-1-AP, Proteintech, China), total Parkin (1:1000, 14060-1-AP, Proteintech, China), phosphorylated Parkin (1:500, bs-19882R, BIOSS, China), LC3 (1:1000, 14600-1-AP, Proteintech, China), SQSTM1/p62 (1:500, AF5384, Affinity, China), Sirt3 (1:1000, 10099-1-AP, Proteintech, China), and GAPDH (1:5000, 10494-1-AP, Proteintech, China). After incubation with HRP-conjugated secondary antibodies, protein bands were visualized using enhanced chemiluminescence (ECL) reagents (SQ203, Epizyme, China) and detected with a chemiluminescence imaging system (Tanon 5200 Multi, Tanon, China). Data analysis was performed using ImageJ software (V1.8.0, National Institute of Health). Proteomic Profiling and Bioinformatics Analysis BMDMs were cultured in vitro and assigned into three experimental groups: uninfected (blank), S. aureus-infected (control), and S. aureus-infected with Mn2+ treatment (Mn2+). A total of nine samples were analyzed (n = 3 biologically independent samples per group). After treatment, cells were harvested, and cell pellets were immediately flash-frozen in liquid nitrogen and stored at −80 °C until further processing. Proteomic sample preparation, LC–MS/MS acquisition and primary data processing were performed by Shanghai Bioprofile Co., Ltd. Proteins were extracted using SDT lysis buffer (4% SDS, 100 mM DTT, 100 mM Tris–HCl, pH 8.0), heated at 100 °C for 3 min and sonicated for 2 min, followed by centrifugation at 16,000 × g for 20 min at 4 °C. Protein concentration was determined by the BCA method. For digestion, samples were processed using filter-aided sample preparation (FASP) on a 10 kDa ultrafiltration unit. Briefly, proteins were reduced with DTT (final 100 mM, 100 °C for 5 min), diluted in UA buffer (8 M urea, 150 mM Tris–HCl, pH 8.0), and centrifuged. Proteins were alkylated with 50 mM iodoacetamide in UA buffer for 30 min at room temperature in the dark, followed by repeated washing with UA buffer and ammonium bicarbonate buffer. Digestion was performed by adding trypsin (6 µg in 40 µL ammonium bicarbonate buffer) and incubating at 37 °C for 16–18 h. Peptides were collected by centrifugation, acidified with 0.1% trifluoroacetic acid, desalted using a C18 cartridge, vacuum-dried, and reconstituted in 0.1% formic acid for LC–MS analysis. For DIA acquisition, peptides were separated on a Vanquish Neo UHPLC system coupled to an Orbitrap Astral mass spectrometer (Thermo Scientific) in positive-ion mode. Mobile phase A was 0.1% formic acid in water and mobile phase B was 0.1% formic acid in 80% acetonitrile. Samples were loaded onto a trap column (PepMap Neo 5 µm C18, 300 µm × 5 mm) and separated on an analytical column (μPAC Neo High Throughput column). A 15-min gradient was used. The electrospray voltage was 2.2 kV. MS1 scans were acquired over 380–980 m/z at a resolution of 240,000 (AGC target 500%, maximum IT 3 ms). MS2 scans were acquired at a resolution of 80,000 (AGC target 500%, maximum IT 3 ms; RF lens 40%) using HCD with normalized collision energy 25%, isolation window 2 Th and a cycle time of 0.6 s. Raw data were processed using DIA-NN v1.8.1 and searched against the UniProtKB Mus musculus database (uniprotkb-Mus musculus (Mouse) [10090]-87434-20240725.fasta). Search parameters included trypsin digestion with up to 1 missed cleavage, carbamidomethyl (C) as a fixed modification and oxidation (M) and acetyl (protein N-term) as variable modifications. Peptide-spectrum match (PSM) FDR and protein-level FDR were controlled at 0.01 (q-value ≤ 0.01). Bioinformatics analyses were performed using R software (version 4.3.1, RStudio, USA). Differentially expressed proteins (DEPs) were identified by comparing the three groups, with selection criteria of an adjusted p-value < 0.05 and an absolute log2(fold change) >1. Functional enrichment analyses, including Subcellular localization, Gene Ontology (GO) annotation and Gene Set Enrichment Analysis (GSEA), were conducted. Fisher’s exact test with multiple testing correction was applied to assess enrichment significance. Protein-protein interaction (PPI) networks were constructed using the STRING database and visualized with Cytoscape software (version 3.9.1, Cytoscape Consortium, USA). Volcano plots and hierarchical clustering were generated using R packages. Data visualization was further performed using online OmicShare Tools (GENE DENOVO, China) (https://www.omicshare.com). Seahorse extracellular flux analysis Cellular bioenergetics were assessed using a Seahorse XF96 extracellular flux analyzer (Agilent). BMDMs were seeded into Seahorse XF cell culture microplates. Cells were infected with S. aureus (MOI = 10) and treated with Mn2+ (100 μM). OCR and ECAR were measured at indicated time points post-infection (3 h and 12 h). Prior to measurement, culture medium was replaced with Seahorse assay medium (pH 7.4) supplemented with glucose, pyruvate, and glutamine, and plates were equilibrated in a non-CO₂ incubator for 45–60 min. For mitochondrial function, a Mito Stress Test was performed by sequential injection of oligomycin (1 μM), FCCP (0.5 μM), and rotenone (0.5 μM)/antimycin A (0.5 μM) to determine basal respiration, ATP-linked respiration, maximal respiration, and non-mitochondrial respiration. For glycolytic capacity, ECAR-based analyses were performed using standard injection schemes (glucose, oligomycin, and 2-deoxyglucose) when indicated. OCR and ECAR values were normalized to cell number, and data were analyzed using Wave software and GraphPad Prism. Blue native PAGE (BN-PAGE) and in-gel activity assays To evaluate the assembly and enzymatic activity of mitochondrial respiratory chain supercomplexes, BN-PAGE followed by in-gel activity staining was performed. Cells were harvested on ice, washed with cold PBS, and mitochondria-enriched fractions were prepared using a mitochondrial isolation procedure (Cell Mitochondria Isolation Kit, C3601, Beyotime, China). Mitochondrial pellets were resuspended in native solubilization buffer and solubilized with digitonin at an optimized detergent-to-protein ratio on ice for 20–30 min. After centrifugation at 12,000–20,000 × g for 20–30 min at 4 °C, supernatants containing solubilized mitochondrial membrane protein complexes were collected. Samples were mixed with BN sample buffer containing Coomassie G-250 and separated on native gradient gels under blue native conditions using standard anode and cathode buffers. After electrophoresis, gels were either (i) subjected to in-gel activity staining or (ii) transferred for immunoblotting as needed (Total OXPHOS Blue Native WB Antibody Cocktail, ab110412, abcam, USA). For in-gel activity assays, gels were incubated in freshly prepared staining solutions specific for complex I, II, or IV at room temperature until bands developed. Complex I activity was visualized using NADH and nitroblue tetrazolium (NBT). Complex II activity was detected using succinate, phenazine methosulfate (PMS), and NBT. Complex IV activity was assessed using 3,3′-diaminobenzidine (DAB) in the presence of cytochrome c. Reactions were stopped by washing in distilled water. SDS-PAGE for respiratory chain components To assess the abundance of mitochondrial electron transport chain (ETC) components, mitochondria-enriched fractions were prepared as described above. Proteins were quantified by BCA assay, resolved by SDS-PAGE, and transferred onto PVDF membranes. Membranes were blocked and probed with antibodies against representative subunits of OXPHOS complexes (Total OXPHOS Blue Native WB Antibody Cocktail, ab110412, abcam, USA). Bands were visualized by chemiluminescence and quantified by ImageJ, normalized to loading controls (TOM20). Sirt3 overexpression in BMDMs In vitro overexpression of Sirt3 in BMDMs was achieved either by pharmacological activation using the Sirt3 activator AR-C1781 or by transfection with a mouse Sirt3 overexpression plasmid (Genechem, Shanghai, China). For pharmacological induction, BMDMs were pretreated with AR-C17 (15 μM) for 24 h. For plasmid-mediated overexpression, BMDMs at approximately 60% confluency were transfected with the Sirt3 overexpression plasmid using Lipofectamine 3000 reagent (L3000001, Invitrogen, USA) according to the manufacturer’s instructions. 9 h after transfection, the culture medium was replaced with fresh medium, and cells were further incubated for an additional 48 h. The efficiency of Sirt3 overexpression was assessed by quantitative real-time PCR (qRT-PCR) and western blot analysis. Following confirmation of successful Sirt3 overexpression, cells were collected for subsequent experiments. Preparation of MZM nano-system The preparation of MZM nano-system consists of three major steps: (1) synthesis of MnO nanoparticles, (2) synthesis of MZ nanoparticles, and (3) macrophage membrane coating. MnO nanoparticles were synthesized by thermal decomposition of manganese-oleate in 1-octadecene under nitrogen protection. The mixture was heated to 160 °C for 1 h to remove oxygen and water, then to 300 °C for 1 h, and cooled to room temperature. The products were precipitated with acetone, collected by centrifugation, and washed. Manganese-oleate was prepared by refluxing MnCl₂·4H₂O and sodium oleate in a mixed solvent of ethanol, water, and n-hexane at 70 °C overnight. MZ nanoparticles were synthesized based on a previously reported method with slight modifications82. Briefly, 2-methylimidazole was dissolved in Milli-Q water and stirred at 35 °C. The pre-synthesized MnO nanoparticles were then rapidly added under vigorous stirring to form a homogeneous solution. Subsequently, an aqueous solution of Zn(NO₃)₂·6H₂O was added, maintaining a Zn2+ to 2-methylimidazole molar ratio of 1:70. The reaction mixture was stirred continuously for 20 min. The resulting product was collected by centrifugation, washed with water, and dried overnight. Macrophage membranes were extracted using a Membrane and Cytosol Protein Extraction Kit (P0033, Beyotime, China) according to the manufacturer’s instructions. Briefly, RAW264.7 cells (a mouse macrophage cell line, SCSP-5036; Cell Bank of the Chinese Academy of Sciences, Shanghai, China) (20–50 million) were resuspended in 1 mL of 1 mM PMSF solution, gently mixed, and subjected to three to four cycles of ultrasonication on ice, followed by incubation on ice for 10–15 min. The lysate was centrifuged at 700 × g for 10 min to remove cellular debris, and the supernatant was collected. Subsequently, the supernatant was centrifuged at 14,000 × g for 30 min to pellet the membrane fractions. For membrane coating, macrophage membranes were fused with MZ nanoparticles by extrusion through polycarbonate membranes with pore sizes of 800 nm and 400 nm using a liposome extruder (Avestin, Canada), followed by bath sonication at 40 kHz and 100 W for 2 min. The resulting suspension was centrifuged at 3000 × g for 30 min to remove uncoated membranes and then at 12,000 × g for 5 min to eliminate soluble membrane proteins. The final pellet containing membrane-coated nanoparticles were MZM, which was collected for further use. Characterization of synthesized materials The morphology of nanoparticles was observed using a transmission electron microscope (JEM-F200, JEOL, Japan) operating at an accelerating voltage of 200 kV. Dynamic light scattering (DLS) measurements and zeta potential analysis were performed using a Zetasizer Nano ZS particle analyzer (Malvern, UK) in ultrapure water at 25 °C with a scattering angle of 173°. X-ray diffraction (XRD) patterns were obtained with an XRDynamic 500 diffractometer (Anton Paar, Austria). For MnO nanoparticles, measurements were performed using a Cobalt (Co) source (Co Kα radiation, λ = 1.7890 Å) to minimize fluorescence background. For ZIF-8 and MZ nanoparticles, a standard Copper (Cu) source (Cu Kα radiation, λ = 1.5418 Å) was employed. All samples were scanned over a 2θ range of 5° to 80° with a scanning speed of 5 °/min. Fourier-transform infrared (FTIR) spectra were recorded using a Nicolet iS20 spectrophotometer (Thermo Fisher Scientific, USA) using the KBr pellet method in the range of 4000–400 cm−1. X-ray photoelectron spectroscopy (XPS) was conducted under ultrahigh vacuum conditions using an Axis Ultra DLD spectrometer (KRATOS, UK) equipped with a monochromatic Al Kα X-ray source (1486.6 eV). The binding energies were calibrated by referencing the C 1 s peak to 284.8 eV. In Vitro Mn2+Release Assay To evaluate Mn2+ release behavior, MZ and MZM nanoparticles with equivalent total Mn content (N) were incubated in buffer solutions at pH 7.4 and pH 5.4. At 2, 4, 8, 12, 24, and 48 h, 3 mL of supernatant was collected, and the Mn2+ concentration (n(x)) was quantified by inductively coupled plasma mass spectrometry (ICP-MS, Agilent 7850, Singapore). The cumulative Mn2+ release rate was calculated using the formula: Mn2+ release rate (%) = (n(x)/N) × 100%. Cellular uptake evaluation Cellular uptake studies were conducted in both normal and S. aureus-activated RAW264.7 cells. After seeding and incubating the cells at 37 °C for 24 h, the culture medium was replaced with fresh medium containing either FITC-labeled MZ nanoparticles (F-MZ) or macrophage membrane-coated FITC-labeled MZ nanoparticles (M-F-MZ). Cells were further incubated with F-MZ or M-F-MZ for 1, 2, or 4 h. At the indicated time points, cells were washed with PBS, stained with LysoTracker Red (C1046, Beyotime, China) for 30 min, and then fixed with paraformaldehyde for 15 min. Nuclei were counterstained with Hoechst 33342. Fluorescence images were acquired using a confocal laser scanning microscope (LSM980, Zeiss, Germany), and quantitative analysis was performed with ImageJ software (version 1.8.0, National Institutes of Health, USA). Targeting ability analysis in SIOM mouse model The targeting ability of MZM nanoparticles to the infected medullary cavity was evaluated in vivo using Cy7-labeled MZ nanoparticles (Cy7-MZ) and macrophage membrane-coated Cy7-MZ nanoparticles (M-Cy7-MZ). SIOM mice and non-infected control mice were administered nanoparticles via caudal vein injection on day 4 post-surgery, corresponding to the obvious inflammatory response observed around day 3. At 1 h post-injection, bilateral femurs and major organs (heart, liver, spleen, lung, and kidney) were harvested from MZM-treated mice for ex vivo fluorescence imaging. Additionally, in vivo biodistribution and fluorescence imaging were conducted at 1, 3, 6, 12, 24, and 48 h post-injection using an IVIS Spectrum imaging system (IVIS Spectrum, PerkinElmer, USA). Fluorescence signals analyzed with Living Image software (version 4.5.2, PerkinElmer, USA). Biosafety evaluation The cytocompatibility of MZM was evaluated in vitro using BMDMs and BMSCs. Cells were seeded in 96-well plates and treated with MZM at equivalent Mn concentrations of 25, 50, 100, 200, and 400 μM for 24, 48, and 72 h. At the indicated time point, cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay (C0038, Beyotime, China) according to the manufacturer’s instructions. Absorbance at 450 nm was measured using a SpectraMax i3x Multi-Mode Detection Platform (Molecular Devices, USA). Additionally, the hemolytic activity was determined by incubating mouse red blood cells at the indicated concentrations. After incubation at 37 °C for 3 h, samples were centrifuged, and the absorbance of the supernatant was measured at 540 nm to quantify hemoglobin release. Deionized water and PBS were used as positive and negative controls, respectively. For in vivo biosafety evaluation, major organs including the heart, liver, spleen, lung, and kidney were collected from mice on day 21 after intravenous injection of MZM via the tail vein. The harvested tissues were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned, and subjected to H&E staining. Histopathological examination was conducted to assess potential MZM-induced tissue toxicity. For hematological and biochemical safety assessment, blood samples were collected from mice at the indicated time points (day 14 and day 21 after treatment). Whole blood was collected into anticoagulant tubes for blood routine test (BRT). For serum biochemistry, blood was allowed to clot at room temperature and then centrifuged to obtain serum. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and creatinine (Cr) were measured using standard clinical chemistry assays according to the manufacturers’ instructions. Mn biodistribution and retention analysis by ICP-MS To quantify systemic exposure and tissue retention of manganese, whole blood and tissues were collected at indicated time points after tail-vein administration of free Mn2+ or MZM (100 μM Mn equivalent; 200 μL per mouse). For short-term biodistribution, samples were harvested within 48 h post-injection (including major organs, contralateral femur, and infected femur). For long-term retention, samples were additionally collected at day 14 (under an every-other-day dosing regimen) and day 21 (7 days after treatment cessation). Tissues were weighed and digested in trace-metal-grade nitric acid (HNO₃) (optionally with H₂O₂) until complete dissolution. Digests were diluted with ultrapure water to a defined final volume, and Mn concentrations were measured using an inductively coupled plasma-mass spectrometer (ICP-MS). Mn levels were normalized to tissue weight and reported as ng/g tissue (or ng/mL). Calibration curves were prepared using Mn standards, and procedural blanks were included for quality control. Systemic S. aureus infection model and organ bacterial burden A systemic S. aureus infection model was established to evaluate the safety risk associated with systemic manganese exposure and to compare free Mn2+ versus MZM delivery. Mice were challenged with S. aureus via intravenous injection (tail vein) at inoculum of 2 × 107 CFU. Subsequently, mice received free Mn2+ or MZM at an equivalent Mn dose (100 μM; 200 μL per mouse) according to the experimental design. Survival was monitored daily for the specified observation period, and humane endpoints were applied in accordance with institutional animal care guidelines. For bacterial burden quantification, major organs (e.g., liver, spleen, kidney, lung, and heart) were harvested aseptically at defined time points, weighed, homogenized in sterile PBS, serially diluted, and plated on agar for CFU enumeration. Mitophagy detection using flow cytometry in SIOM mouse model Bone marrow cells were isolated by flushing the femoral cavities with serum-free RPMI-1640 medium, filtered through a 70 μm cell strainer, and collected by centrifugation at 1500 × g for 5 min. Red blood cells were lysed using ACK lysis buffer on ice, and remaining cells were resuspended in 0.1% BSA-PBS and adjusted to 1 × 10⁶ cells/100 μL. After blocking Fc receptors with anti-CD16/32 antibody (101320, Biolegend, USA), cells were stained with anti-CD11b (BV605, 101257, Biolegend, USA), anti-F4/80 (APC-Cy7, 157315, Biolegend, USA), and a live/dead viability dye (eFluor 450, L34963, Thermo, USA). Mitophagy detection was performed using a Mitophagy Detection Kit (PerCP-Cy5.5, MD01, Dojindo, Japan) combined with a Lysosome Tracker (FITC, MD01, Dojindo, Japan). Following antibody staining, cells were incubated with the mitophagy/lysosome dyes at 37 °C for 30 min in the dark. After washing, cells were resuspended in PBS and analyzed by flow cytometry. Data were collected using a BD LSRII flow cytometer (BD Biosciences, USA) and analyzed based on CD11b⁺F4/80⁺ gated macrophage populations using FlowJo software (version 10, FlowJo, USA). Flow cytometry analysis of immune cell composition in infected femoral cavity To characterize the immune microenvironment in the infected medullary cavity, bone marrow cells were isolated from femurs as described above, followed by red blood cell lysis and Fc blocking. Cells were stained with fluorophore-conjugated antibodies (anti-CD11b, PerCp/Cy5.5, E-AB-F1081J, elabscience, China; anti-Ly6G, APC, E-AB-F1108E, elabscience, China; anti-F4/80, APC, 123115, Biolegend, USA; anti-CD3, PerCp/Cy5.5, E-AB-F1013J, elabscience, China; anti-CD4, PE, E-AB-F1097D, elabscience, China; anti-CD8, APC, AN00576E, elabscience, China) to identify myeloid and lymphoid populations. Neutrophils were defined as CD11b⁺Ly6G⁺ cells; macrophages were defined as CD11b⁺F4/80⁺ cells. T lymphocytes were defined as CD3⁺ cells (further separated into CD4⁺ and CD8⁺ subsets). A live/dead viability dye (Zombie yellow, 423103, Biolegend, USA) was included to exclude dead cells. Data acquisition was performed on a BD LSRII flow cytometer (BD Biosciences, USA) and analyses were conducted using FlowJo software (version 10, FlowJo, USA). Histological analysis Paraffin-embedded femurs were coronally sectioned at a thickness of 4 μm and stained with H&E following the manufacturer’s instructions (C0105S, Beyotime, China). Briefly, sections were deparaffinized, rehydrated, stained with hematoxylin for 3 min, differentiated in 1% hydrochloric acid ethanol for 2 s, and subsequently counterstained with eosin for 30 s. To assess histopathological changes in bone tissue, a modified version of Smeltzer’s scoring system83 was applied. The modification was based on characteristic histological features of acute and chronic osteomyelitis observed in human patients84 and findings from a murine osteomyelitis model41. Each sample received a cumulative score derived from four parameters: intraosseous acute inflammation (presence or absence of small foci of neutrophils with or without intramedullary abscess), intraosseous chronic inflammation (large or multiple foci of neutrophils with or without intramedullary fibrosis), periosteal reaction (periosteal inflammation with or without subperiosteal abscess formation), and bone necrosis (necrosis with or without sequestrum formation). Each parameter was individually scored on a scale from 0 (normal) to 4 (severe). Scanning Electron Microscopy (SEM) of inserted micro screws Micro screws were retrieved and grouped according to experimental conditions. Screws were rinsed twice with PBS by gentle shaking, then transferred into 24-well plates containing 2.5% glutaraldehyde solution for fixation at 4 °C for 24 h. Fixed samples were subsequently washed twice with PBS and dehydrated through a graded ethanol series (30%, 50%, 70%, 90%, and three changes of 100% ethanol), each for 5 min at room temperature. After dehydration, screws were frozen at −80 °C for 2 h, followed by overnight freeze-drying. Prior to SEM observation, samples were sputter-coated with gold and imaged at magnifications of 1000× and 2500× using a scanning electron microscope (Axia ChemiSEM, FEI, USA) operating at an accelerating voltage of 10 kV and a beam current of 64 pA. Micro-computed tomography (micro-CT) analysis At 14 and 21 days post-infection, the right femurs of mice were scanned using high-resolution micro-computed tomography (micro-CT) (SkyScan 1276, Bruker, Germany). Scanning parameters included a voxel size of 6 μm, a current of 145 mA, a voltage of 55 kV, and an integration time of 400 ms. Cortical bone structure and trabecular microarchitecture were evaluated following previously described protocols25. Bone mineral density (BMD) was calibrated against ceramic standard phantoms. Raw scan data were reconstructed into two-dimensional images using NRecon software (version 1.6.8, Bruker, Germany). Femur orientation was recalibrated across the coronal, sagittal, and transverse planes using DataViewer software (version 1.5.4, Bruker, Germany). Structural parameters were quantitatively analyzed with CTAn software (version 1.9, Bruker, Germany) in predefined regions of interest (ROIs). For cortical bone analysis, the ROI encompassed 1200 slices (approximately 7.2 mm) centered around the monocortical defect associated with the self-tapping screw. For trabecular bone assessment, analysis was performed within a longitudinal span from 0.444 mm distal to the growth plate to 1.2 mm proximally. Evaluated trabecular parameters included bone mineral density (BMD), bone volume to total volume ratio (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular bone separation (Tb.Sp). Three-dimensional bone morphology was reconstructed and visualized using CTVol software (version 2.0, Bruker, Germany). All scanning and analysis procedures were conducted in accordance with established guidelines for micro-CT evaluation of rodent bone structures85. Checkerboard assay for Mn2+and gentamicin The potential interaction between Mn2+ and gentamicin against S. aureus was evaluated using a standard broth microdilution checkerboard assay. Briefly, two-fold serial dilutions of gentamicin were prepared along one axis of a 96-well plate, while two-fold serial dilutions of Mn2+ were prepared along the other axis. S. aureus was inoculated into each well at a standardized starting density (5 × 105 CFU/mL) in appropriate growth medium. Plates were incubated at 37 °C for 16–18 h, and the MIC was defined as the lowest concentration that prevented visible growth. SIOM cohort without gentamicin for factorial analysis To determine whether MZM efficacy depended on concurrent antibiotic treatment, an additional SIOM cohort was established in which gentamicin was omitted. Mice were assigned to a factorial design including MZM (±) and gentamicin (±) conditions. Treatments were administered according to the same dosing schedule as the main SIOM experiment, and bacterial burdens, histological scoring, and S. aureus+ area in the infected femur cavity were quantified at the indicated endpoint. Statistics and reproducibility No statistical method was used to predetermine sample size. Sample sizes were selected on the basis of common practice in the field, our previous experience with similar experiments, and preliminary observations of effect size and variability. For in vitro experiments, replicate numbers were selected to ensure reproducibility across independent experiments, and samples were assigned according to the predefined experimental design and processed in parallel under identical conditions. For in vivo experiments, group sizes were based on commonly used sample sizes in comparable mouse osteomyelitis studies and were considered sufficient to detect biologically meaningful differences between groups. Mice were randomly allocated to the experimental groups after model establishment, while relevant covariates including strain, sex, age and body weight were controlled across groups. The investigators were not blinded to allocation during experiments, but outcome assessment for histological scoring and Micro-CT analysis were performed in a blinded manner. No data were excluded from the analyses. All data were expressed as means ± standard errors of the mean (SEM). Statistical analysis was performed using GraphPad Prism 9 (GraphPad Software, San Diego, USA). Normality was checked via Shapiro–Wilk test. For comparisons between two groups, an unpaired two-tailed Student’s t-test was used. For multiple comparisons, one-way ANOVA with Turkey’s post hoc test was used. For factorial experiments involving MZM and gentamicin, bacterial burden data were analyzed by two-way ANOVA with factors “MZM” and “gentamicin,” including an interaction term. A p-value less than 0.05 was considered statistically significant. All statistical graphs were generated using GraphPad Prism 9. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information supplementary information Reporting summary Transparent Peer Review file supplementary information Reporting summary Transparent Peer Review file Source data Source Data Source Data